MEWIGEN gene list
Please find our complete genetic analysis service list below
Gene list
Search by:
Gene | Gene Synonym | Gene-OMIM | Disease | Acronym | Disease-OMIM | Method | Filter 1 A-Z | Filter 2 Group |
---|---|---|---|---|---|---|---|---|
AARS | 601065 | Charcot-Marie-Tooth neuropathy, axonal, type 2N | CMT2N | 613287 | SEQ, NGS | A | Neuro | |
AARS | 601065 | Epileptic encephalopathy, early infantile, type 29 | EIEE29 | 616339 | SEQ, NGS | A | Epi | |
ABCA4 | 601691 | Stargardt disease type 1 | STGD1 | 248200 | SEQ, MLPA, NGS | A | Sensory | |
ABCB11 | 603201 | Cholestasis, benign recurrent intrahepatic, type 2 | BRIC2 | 605479 | SEQ, NGS | A | Meta | |
ABCB11 | 603201 | Cholestasis, progressive familial intrahepatic, type 2 | PFIC2 | 601847 | SEQ, NGS | A | Meta | |
ABCB4 | 171060 | Cholelithiasis, low phospholipid-associated | LPAC, Gallbladder disease 1 | 600803 | SEQ, MLPA, NGS | A | Meta | |
ABCB4 | 171060 | Cholestasis, intrahepatic, of pregnancy, 3 | ICP3 | 614972 | SEQ, MLPA, NGS | A | Meta | |
ABCB4 | 171060 | Cholestasis, progressive familial intrahepatic, type 3 | PFIC3 | 602347 | SEQ, MLPA, NGS | A | Meta | |
ABCC8 | SUR1 | 600509 | Hyperinsulinemic hypoglycemia, familial, type 1 | HHF1, hyperinsulinism, familial type 1 | 256450 | SEQ, MLPA, NGS | A | Meta |
ACTA2 | 102620 | Thoracic aortic aneurysm type 6 | AAT6, FAA6 | 611788 | SEQ, NGS | A | Tissue | |
ACVRL1 | 601284 | Telangiectasia, hereditary hemorrhagic, type 2 | HHT2, Osler-Rendu-Weber disease type 2 | 600376 | SEQ, MLPA, NGS | A | Tissue | |
AFG3L2 | 604581 | Spastic ataxia, autosomal recessive, type 5 | SPAX5 | 614487 | SEQ, NGS | A | Neuro | |
AFG3L2 | 604581 | Spinocerebellar ataxia type 28 | SCA28 | 610246 | SEQ, NGS | A | Neuro | |
AGGF1, mutation exon 3: c.397G>A, p.E133K [VG5Q] | 608464 | Klippel-Trenaunay-Weber syndrome, predisposition | KTS | 149000 | SEQ | A | Syndro | |
AGPAT2 | 603100 | Lipodystrophy, congenital generalized, type 1 | CGL1, Berardinelli-Seip syndrome | 608594 | SEQ, NGS | A | Meta | |
ALAS2 | 301300 | Protoporphyria, erythropoietic, X-linked | XLEPP | 300752 | SEQ, NGS | A | Meta | |
ALAS2 | 301300 | Sideroblastic Anemia, X-linked | SIDBA1 | 300751 | SEQ, NGS | A | Coagul | |
ALDH4A1 | P5CDH | 606811 | Hyperprolinemia, type II | HYRPRO2, P5CDH1-Defizienz | 239510 | SEQ, NGS | A | Meta |
ALDOB | 612724 | Fructose intolerance, hereditary | Fructosemia, aldolase B deficiency | 229600 | SEQ, MLPA, NGS | A | Meta | |
ALPL | 171760 | Hypophosphatasia, adult | HPPA | 146300 | SEQ, MLPA, NGS | A | Meta | |
ALPL | 171760 | Hypophosphatasia, childhood | HPPC | 241510 | SEQ, MLPA, NGS | A | Meta | |
ALPL | 171760 | Hypophosphatasia, infantile | HPPI | 241500 | SEQ, MLPA, NGS | A | Meta | |
ALPL | 171760 | Odontohypophosphatasia | HPPO | 146300 | SEQ, MLPA, NGS | A | Meta | |
ALS2 | KIAA1563 | 606352 | Amyotrophic lateral sclerosis type 2, juvenile | ALS2 | 205100 | SEQ, NGS | A | Neuro |
ALS2 | 606352 | Primary lateral sclerosis, juvenile | PLSJ | 606353 | SEQ, NGS | A | Neuro | |
ALS2 | KIAA1563 | 606352 | Spastic paralysis, infantile-onset, ascending | IAHSP | 607225 | SEQ, NGS | A | Neuro |
AMPD1 | 102770 | AMP deaminase deficiency | Myoadenylat deaminase deficiency | 615511 | SEQ, NGS | A | Neuro | |
AMT | GCST | 238310 | Glycine encephalopathy | GCE, Hyperglycinemia nonketotic (NKH) | 605899 | SEQ, MLPA, NGS | A | Meta |
ANG | 105850 | Amyotrophic lateral sclerosis type 9 | ALS9 | 611895 | SEQ, NGS | A | Neuro | |
ANK1 | 612641 | Spherocytosis, type 1 | HS1 | 182900 | SEQ, NGS | A | Meta | |
ANO5 | 608662 | Gnathodiaphyseal dysplasia | GDD | 166260 | SEQ, MLPA, NGS | A | Syndro | |
ANO5 | 608662 | Miyoshi muscular dystrophy 3 | MMD3 | 613319 | SEQ, MLPA, NGS | A | Neuro | |
ANO5 | 608662 | Muscular dystrophy, limb-girdle, type 2L | LGMD2L | 611307 | SEQ, MLPA, NGS | A | Neuro | |
ANOS1 | KAL1 | 300836 | Kallmann syndrome 1 | Hypogonadotropic hypogonadism 1 with or without anosmia, HH1 | 308700 | SEQ, MLPA, NGS | A | Syndro |
APC | 611731 | Attenuated familial adenomatous polyposis | AFAP | 175100 | SEQ, MLPA, NGS | A | Tumor | |
APC | 611731 | Familial adenomatous polyposis coli, familial polyposis of the colon | FAP | 175100 | SEQ, MLPA, NGS | A | Tumor | |
APOB p.R3527Q [R3500Q], p.R3558C [R3531C] | 107730 | Apolipoprotein B100, familial ligand-defective | Hypercholesterolemia, familial, 2, FCHL2 | 144010 | SEQ | A | Meta | |
APOB p.R3527Q [R3500Q], p.R3558C [R3531C] | 107730 | Hypercholesterolemia, familial, type 2 | FHCL2 | 144010 | SEQ | A | Meta | |
APOE E2/E3/E4-Allele | 107741 | Alzheimer disease type 2, familial | AD2 | 104310 | SEQ | A | Neuro | |
APP | 104760 | Alzheimer disease type 1, familial | AD | 104300 | SEQ, MLPA, NGS | A | Neuro | |
APTX | 606350 | Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | AOA1 | 208920 | SEQ, MLPA, NGS | A | Neuro | |
AR | 313700 | Androgen insensitivity | AIS | 300068 | SEQ, MLPA, NGS | A | Meta | |
AR | 313700 | Androgen insensitivity, partial, with or without breast cancer | PAIS | 312300 | SEQ, MLPA, NGS | A | Meta | |
AR, CAG repeat in exon 1 | 313700 | Spinal and bulbar muscular atrophy | SBMA, Kennedy disease | 313200 | REP | A | Neuro | |
ARG1 | 608313 | Argininemia | Arginase deficiency | 207800 | SEQ, NGS | A | Meta | |
ARG1 | 608313 | Argininemia | Arginase deficiency | 207800 | SEQ, NGS | A | Path | |
ARMS2 p.A69S | LOC387715 | 611313 | Age-related macular degeneration 8 | ARMD8 | 613778 | SEQ | A | Sensory |
ARSA | 607574 | Metachromatic leukodystrophy | Arylsulfatase A deficiency, diffuse cerebral sclerosis | 250100 | SEQ, NGS | A | Meta | |
ARX | 300382 | Corpus callosum, agenesis of, with abnormal genitalia | Proud syndrome | 300004 | SEQ, MLPA, NGS | A | Syndro | |
ARX | 300382 | Epileptic encephalopathy, early infantile, type 1 | EIEE1, X-linked infantile spasm syndrome, ISSX, West syndrome | 308350 | SEQ, MLPA, NGS | A | Epi | |
ARX | 300382 | Lissencephaly (X-linked) with ambiguous genitalia | 300215 | SEQ, MLPA, NGS | A | Syndro | ||
ARX | 300382 | X-linked mental retardation with dystonia, ataxia and seizures | Partington syndrome | 309510 | SEQ, MLPA, NGS | A | Epi | |
ASL | 608310 | Argininosuccinase deficiency | Argininosuccinic aciduria | 207900 | SEQ, NGS | A | Path | |
ASL | 608310 | Argininosuccinase deficiency | Argininosuccinic aciduria | 207900 | SEQ, NGS | A | Meta | |
ASS1 | 603470 | Citrullinemia, classic | Citrullinemia type I, CTLN1 | 215700 | SEQ, NGS | A | Meta | |
ASS1 | 603470 | Citrullinemia, classic | Citrullinemia type I, CTLN1 | 215700 | SEQ, NGS | A | Path | |
ATL1 | SPG3A | 606439 | Spastic paraplegia type 3, autosomal dominant | Strumpell disease | 182600 | SEQ, MLPA, NGS | A | Neuro |
ATM | 607585 | Ataxia teleangiectasia | Louis-Bar-syndrome | 208900 | SEQ, MLPA, NGS | A | Neuro | |
ATM | 607585 | Ataxia teleangiectasia | Louis-Bar syndrome | 208900 | SEQ, MLPA, NGS | A | Tumor | |
ATM | 607585 | Familial breast cancer | 114480 | SEQ, MLPA, NGS | A | Tumor | ||
ATP1A2 | 182340 | Alternating hemiplegia of childhood 1 | AHC1 | 104290 | SEQ, MLPA, NGS | A | Neuro | |
ATP1A2 | 182340 | Familial hemiplegic migraine type 2 | FHM2 | 602481 | SEQ, MLPA, NGS | A | Neuro | |
ATP1A3 | 182350 | Alternating hemiplegia of childhood 2 | AHC2 | 614820 | SEQ, MLPA, NGS | A | Neuro | |
ATP1A3 | 182350 | Cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing loss | CAPOS-syndrome | 601338 | SEQ, MLPA, NGS | A | Neuro | |
ATP1A3 | 182350 | Dystonia type 12 | DYT12 | 128235 | SEQ, MLPA, NGS | A | Neuro | |
ATP2A2 | 108740 | Darier-White disease | DAR, keratosis follicularis | 124200 | SEQ, NGS | A | Geno | |
ATP2C1 | 604384 | Hailey-Hailey disease | Benign familial pemphigus, BCPM | 169600 | SEQ, NGS | A | Geno | |
ATP7B | 606882 | Wilson disease | 277900 | SEQ, MLPA, NGS | A | Meta | ||
ATP8B1 | 602397 | Cholestasis, benign recurrent intrahepatic, type 1 | BRIC1, Summerskill syndrome | 243300 | SEQ, NGS | A | Meta | |
ATP8B1 | 602397 | Cholestasis, intrahepatic, of pregnancy, 1 | ICP1 | 147480 | SEQ, NGS | A | Meta | |
ATP8B1 | 602397 | Cholestasis, progressive familial intrahepatic, type 1 | PFIC1, Byler Disease | 211600 | SEQ, NGS | A | Meta | |
ATRX | 300032 | Alpha-thalassemia/mental retardation syndrome, X-linked | ATRX | 301040 | SEQ, MLPA, NGS | A | Syndro | |
ATXN1 repeat | 601556 | Spinocerebellar ataxia type 1 | SCA1 | 164400 | REP | A | Neuro | |
ATXN2 repeat | 601517 | Spinocerebellar ataxia type 2 | SCA2 | 183090 | REP | A | Neuro | |
ATXN3 repeat | 607047 | Spinocerebellar ataxia type 3 | SCA3, Machado-Joseph disease | 109150 | REP | A | Neuro | |
ATXN7 repeat | 607640 | Spinocerebellar ataxia type 7 | SCA7 | 164500 | REP | A | Neuro | |
ATXN8OS repeat | 603680 | Spinocerebellar ataxia type 8 | SCA8 | 608768 | REP | A | Neuro | |
AXIN2 | 604025 | Oligodontia-colorectal cancer syndrome | ODCRCS | 608615 | SEQ, NGS | A | Syndro | |
BEST1 | 607854 | Bestrophinopathy, autosomal recessive | ARB | 611809 | SEQ, MLPA, NGS | B | Sensory | |
BEST1 | 607854 | Early-onset vitelliform macular dystrophy | VMD2 | 153700 | SEQ, MLPA, NGS | B | Sensory | |
BEST1 | 607854 | Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma | MRCS | 193220 | SEQ, MLPA, NGS | B | Sensory | |
BEST1 | 607854 | Vitreoretinochoroidopathy | VRCP | 193220 | SEQ, MLPA, NGS | B | Sensory | |
BMP15 | 300247 | Premature ovarian failure type 4 | POF4 | 300510 | SEQ, NGS | B | Syndro | |
BMPR1A | 601299 | Hereditary mixed polyposis syndrome type 2 | HMPS2 | 610069 | SEQ, MLPA, NGS | B | Tumor | |
BMPR1A | 601299 | Juvenile, intestinal polyposis | JIP | 174900 | SEQ, MLPA, NGS | B | Tumor | |
BRAF | 164757 | Cardiofaciocutaneous syndrome 1 | CFC1 | 115150 | SEQ, NGS | B | Syndro | |
BRAF | 164757 | LEOPARD syndrome 3 | LPRD3 | 613707 | SEQ, NGS | B | Syndro | |
BRAF | 164757 | Noonan syndrome 7 | NS7 | 613706 | SEQ, NGS | B | Syndro | |
BRCA1 | 113705 | Familial breast-ovarian cancer type 1 | HBOC1 | 604370 | SEQ, MLPA, NGS | B | Tumor | |
BRCA1 | 113705 | Pancreatic cancer, susceptibility, type 4 | PNCA4 | 614320 | SEQ, MLPA, NGS | B | Tumor | |
BRCA2 | 600185 | Familial breast-ovarian cancer type 2 | HBOC2 | 612555 | SEQ, MLPA, NGS | B | Tumor | |
BRCA2 | 600185 | Pancreatic cancer, susceptibility, type 2 | PNCA2 | 613347 | SEQ, MLPA, NGS | B | Tumor | |
BSCL2 | 606158 | Lipodystrophy, congenital generalized, type 2 | CGL2, Berardinelli-Seip syndrome | 269700 | SEQ, NGS | B | Tissue | |
BSCL2 | 606158 | Lipodystrophy, congenital generalized, type 2 | CGL2, Berardinelli-Seip syndrome | 269700 | SEQ, NGS | B | Meta | |
BSCL2 | 606158 | Neuropathy, distal hereditary motor, type VA | HMN5A | 600794 | SEQ, NGS | B | Neuro | |
BSCL2 | 606158 | Spastic paraplegia type 17, autosomal dominant | SPG17, Silver syndrome | 270685 | SEQ, NGS | B | Neuro | |
BTBD9 rs3923809 | 611237 | Restless legs syndrome, periodic limb movements in sleep, type 6 | RLS6 | 611185 | SEQ | B | Neuro | |
C10ORF11 | 614537 | Albinism, oculocutaneous, type 7 | OCA7 | 615179 | SEQ, NGS | C | Meta | |
C12orf57 | 615140 | Temtamy syndrome | TEMTYS | 218340 | SEQ, NGS | C | Syndro | |
C9orf72 repeat | 614260 | Frontotemporal dementia and/or amyotrophic lateral sclerosis | FTDALS1 | 105550 | REP | C | Neuro | |
CA8 | 114815 | Cerebeller ataxia, mental retardation and dysequilibrium syndrome 3 | CAMRQ3 | 613227 | SEQ, NGS | C | Neuro | |
CACNA1A | 601011 | Episodic ataxia type 2 | episodic ataxia with myokymia | 108500 | SEQ, MLPA, NGS | C | Neuro | |
CACNA1A | 601011 | Familial hemiplegic migraine type 1 | FHM1 | 141500 | SEQ, MLPA, NGS | C | Neuro | |
CACNA1A exon 47 CAG repeat | 601011 | Spinocerebellar ataxia type 6 | SCA6 | 183086 | REP | C | Neuro | |
CACNA1C | 114205 | Brugada syndrome type 3 | BRGDA3 | 611875 | SEQ, NGS | C | Cardio | |
CACNA1C | 114205 | Timothy syndrome | TS, Long QT syndrome with syndactyly | 601005 | SEQ, NGS | C | Cardio | |
CACNA1S | 114208 | Hypokalemic periodic paralysis type 1 | HOKPP1 | 170400 | SEQ, MLPA, NGS | C | Neuro | |
CACNA1S | 114208 | Malignant hyperthermia susceptibility 5 | MHS5 | 601887 | SEQ, MLPA, NGS | C | Meta | |
CACNA1S | 114208 | Thyrotoxic periodic paralysis type 1 | TTPP1 | 188580 | SEQ, MLPA, NGS | C | Neuro | |
CACNB2 | 600003 | Brugada syndrome type 4 | BRGDA4 | 611876 | SEQ, NGS | C | Cardio | |
CACNB4 | 601949 | Episodic ataxia type 5 | EA5 | 613855 | SEQ, NGS | C | Neuro | |
CACNB4 | 601949 | Idiopathic generalized epilepsy, susceptibility to, 9 | EIG9 | 607682 | SEQ, NGS | C | Epi | |
CACNB4 | 601949 | Juvenile myoclonus epilepsy, susceptibility, 6 | EJM6 | 607682 | SEQ, NGS | C | Epi | |
CALM3 | 114183 | Catecholaminergic polymorphic ventricular tachycardia-6 | CPVT6 | 618782 | SEQ, NGS | C | Cardio | |
CALM3 | 114183 | Long QT syndrome 16 | LQT16 | 618782 | SEQ, NGS | C | Cardio | |
CAPN3 | 114240 | Muscular dystrophy, limb-girdle, type 2A | LGMD2A | 253600 | SEQ, MLPA, NGS | C | Neuro | |
CAV1 | 601047 | Lipodystrophy, congenital generalized, type 3 | CGL3, Berardinelli-Seip syndrome | 612526 | SEQ, NGS | C | Meta | |
CAV1 | 601047 | Lipodystrophy, familial partial, type 7 | FPLD7, lipodystrophy congenital cataracts, with or without neurodegeneration syndrome (LCCNS) | 606721 | SEQ, NGS | C | Meta | |
CAV1 | 601047 | Pulmonary hypertension, primary, 3 | PPH3 | 615343 | SEQ, NGS | C | Cardio | |
CAV3 | 601253 | Cardiomyopathy, familial hypertrophic | CMH | 192600 | SEQ, MLPA, NGS | C | Cardio | |
CAV3 | 601253 | Creatine phosphokinase, elevated serum | high serum CPK | 123320 | SEQ, MLPA, NGS | C | Cardio | |
CAV3 | 601253 | Long QT syndrome 9 | LQT9 | 611818 | SEQ, MLPA, NGS | C | Cardio | |
CAV3 | 601253 | Muscular dystrophy, limb-girdle, type 1C | LGMD1C | 607801 | SEQ, MLPA, NGS | C | Neuro | |
CAV3 | 601253 | Myopathy, distal, Tateyama type | MPDT | 614321 | SEQ, MLPA, NGS | C | Neuro | |
CAV3 | 601253 | Rippling muscle disease | RMD | 606072 | SEQ, MLPA, NGS | C | Neuro | |
CBL | 165360 | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia | NSLL, CBL syndrome | 613563 | SEQ, NGS | C | Syndro | |
CCBE1 | 612753 | Hennekam syndrome | Hennekam lymphangiectasia-lymphedema syndrome, HKLLS1 | 235510 | SEQ, NGS | C | Syndro | |
CDH1 | 192090 | Hereditary diffuse gastric cancer | 137215 | SEQ, MLPA, NGS | C | Tumor | ||
CDK4 exon 2 | 123829 | Familial atypical mole-malignant melanoma syndrome | FAMMM, cutaneous malignant melanoma-1, CMM1, familial melanoma, MLM | 155600 | SEQ | C | Tumor | |
CDK4 exon 2 | 123829 | Melanoma-pancreatic cancer syndrome, familial | MPCS, Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome FAMMM-PC | 606719 | SEQ | C | Tumor | |
CDK4 only exon 2 and MLPA | 123829 | Cutaneous malignant melanoma-3 | CMM3 | 609048 | SEQ, MLPA | C | Neuro | |
CDKL5 | 300203 | Epileptic encephalopathy, early infantile, type 2 | EIEE2 | 300672 | SEQ, MLPA, NGS | C | Epi | |
CDKN1B | 600778 | Multiple endocrine neoplasia type 4 | MEN4 | 610755 | SEQ, MLPA, NGS | C | Tumor | |
CDKN1C | KIP2 | 600856 | Beckwith-Wiedemann syndrome | BWS | 130650 | SEQ, MLPA, NGS | C | Syndro |
CDKN1C | KIP2 | 600856 | Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies | IMAGE syndrome | 614732 | SEQ, MLPA, NGS | C | Syndro |
CDKN2A | 600160 | Familial atypical mole-malignant melanoma syndrome | FAMMM, familial melanoma, MLM | 155600 | SEQ, MLPA, NGS | C | Tumor | |
CDKN2A | 600160 | Melanoma-pancreatic cancer syndrome, familial | MPCS, Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome FAMMM-PC | 606719 | SEQ, MLPA, NGS | C | Tumor | |
CFH p.Y402H | HF | 134370 | Age-related macular degeneration 4 | ARMD4 | 610698 | SEQ | C | Sensory |
CFTR | 602421 | Congenital bilateral absence of vas deferens | CBAVD | 277180 | SEQ, MLPA, NGS | C | Syndro | |
CFTR | 602421 | Cystic fibrosis | CF, mucoviscidosis | 219700 | SEQ, MLPA, NGS | C | Meta | |
CFTR | 602421 | Hereditary pancreatitis | PCTT | 167800 | SEQ, MLPA, NGS | C | Tumor | |
CHEK2 | 604373 | Familial breast cancer | 114480 | SEQ, MLPA, NGS | C | Tumor | ||
CHEK2 | 604373 | Li-Fraumeni syndrome 2 | LFS2 | 609265 | SEQ, MLPA, NGS | C | Tumor | |
CHMP2B | 609512 | Frontotemporal dementia type 3 | FTD3 | 600795 | SEQ, NGS | C | Neuro | |
CHST14 | 608429 | Ehlers-Danlos syndrome, musculocontractural type 1 | EDSMC1 | 601776 | SEQ, NGS | C | Tissue | |
CIDEC | 612120 | Lipodystrophy, familial partial, type 5 | FPLD5 | 615238 | SEQ, NGS | C | Meta | |
CLCN1 | 118425 | Myotonia congenita Becker, autosomal recessive | 255700 | SEQ, MLPA, NGS | C | Neuro | ||
CLCN1 | 118425 | Myotonia congenita Thomsen, autosomal dominant | 160800 | SEQ, MLPA, NGS | C | Neuro | ||
CLN6 | 606725 | Ceroid lipofuscinosis, neuronal, 4a, autosomal recessive | CLN4A, adult onset, Kufs type | 204300 | SEQ, MLPA, NGS | C | Meta | |
CLN6 | 606725 | Ceroid lipofuscinosis, neuronal, 6 | CLN6, late infantile, variant | 601780 | SEQ, MLPA, NGS | C | Meta | |
COL11A1 | 120280 | Fibrochondrogenesis type 1 | FBCG1 | 228520 | SEQ, MLPA, NGS | C | Tissue | |
COL11A1 | 120280 | Marshall syndrome | MRSHS | 154780 | SEQ, MLPA, NGS | C | Tissue | |
COL11A1 | 120280 | Stickler syndrome type 2, autosomal dominant | STL2 | 604841 | SEQ, MLPA, NGS | C | Tissue | |
COL11A2 | 120290 | Deafness, autosomal dominant, type 13 | DFNA13 | 601868 | SEQ, NGS | C | Sensory | |
COL11A2 | 120290 | Deafness, autosomal recessive, type 53 | DFNB53 | 609706 | SEQ, NGS | C | Sensory | |
COL11A2 | 120290 | Fibrochondrogenesis type 2 | FBCG2 | 614524 | SEQ, NGS | C | Tissue | |
COL11A2 | 120290 | Otospondylomegaepiphyseal dysplasia, autosomal dominant | OSMEDA, Weissenbacher-Zweymuller syndrome, WZS, formerly: Stickler syndrome type 3, STL3 | 184840 | SEQ, NGS | C | Syndro | |
COL11A2 | 120290 | Otospondylomegaepiphyseal dysplasia, autosomal recessive | OSMED | 215150 | SEQ, NGS | C | Tissue | |
COL11A2 | 120290 | Stickler syndrome type 3, autosomal dominant | STL3 | 184840 | SEQ, NGS | C | Tissue | |
COL1A1 | 120150 | Ehlers-Danlos syndrome, arthrochalasia type 1 | EDSARTH1 | 130060 | SEQ, MLPA, NGS | C | Tissue | |
COL1A1 | 120150 | Osteogenesis imperfecta, type I | OI1 | 166200 | SEQ, MLPA, NGS | C | Tissue | |
COL1A1 | 120150 | Osteogenesis imperfecta, type II | OI2 | 166210 | SEQ, MLPA, NGS | C | Tissue | |
COL1A1 | 120150 | Osteogenesis imperfecta, type III | OI3 | 259420 | SEQ, MLPA, NGS | C | Tissue | |
COL1A1 | 120150 | Osteogenesis imperfecta, type IV | OI4 | 166220 | SEQ, MLPA, NGS | C | Tissue | |
COL1A2 | 120160 | Ehlers-Danlos syndrome, arthrochalasia type 2 | EDSARTH2 | 617821 | SEQ, MLPA, NGS | C | Tissue | |
COL1A2 | 120160 | Osteogenesis imperfecta, type II | OI2 | 166210 | SEQ, MLPA, NGS | C | Tissue | |
COL1A2 | 120160 | Osteogenesis imperfecta, type III | OI3 | 259420 | SEQ, MLPA, NGS | C | Tissue | |
COL1A2 | 120160 | Osteogenesis imperfecta, type IV | OI4 | 166220 | SEQ, MLPA, NGS | C | Tissue | |
COL2A1 | 120140 | Achondrogenesis type 2 | ACG2 | 200610 | SEQ, MLPA, NGS | C | Tissue | |
COL2A1 | 120140 | Kniest dysplasia | 156550 | SEQ, MLPA, NGS | C | Tissue | ||
COL2A1 | 120140 | Perthes disease | Legg-Calve-Perthes disease | 150600 | SEQ, MLPA, NGS | C | Tissue | |
COL2A1 | 120140 | Spondyloepiphyseal dysplasia congenita | SEDC | 183900 | SEQ, MLPA, NGS | C | Tissue | |
COL2A1 | 120140 | Stickler syndrome type I, autosomal dominant | STL1 | 108300 | SEQ, MLPA, NGS | C | Tissue | |
COL3A1 | 120180 | Ehlers-Danlos syndrome type IV | vascular type | 130050 | SEQ, MLPA, NGS | C | Tissue | |
COL4A1 | 120130 | Porencephaly type 1 | POREN1, Brain Small Vessel Disease | 175780 | SEQ, NGS | C | Neuro | |
COL4A2 | 120090 | Porencephaly type 2 | POREN2, Brain Small Vessel Disease | 2614483 | SEQ, NGS | C | Neuro | |
COL4A3 | 120070 | Alport syndrome 2, autosomal recessive | ATS2 | 203780 | SEQ, MLPA, NGS | C | Kidney | |
COL4A3 | 120070 | Alport syndrome 3, autosomal dominant | ATS3 | 104200 | SEQ, MLPA, NGS | C | Kidney | |
COL4A3 | 120070 | Alport syndrome 3, autosomal dominant | ATS3 | 104200 | SEQ, MLPA, NGS | C | Syndro | |
COL4A3 | 120070 | Hematuria, familial benign | Thin-basement-membrane nephropathy, TBMN | 141200 | SEQ, MLPA, NGS | C | Kidney | |
COL4A3 | 120070 | Hematuria, familial benign | Thin-basement-membrane nephropathy, TBMN | 141200 | SEQ, MLPA, NGS | C | Syndro | |
COL4A4 | 120131 | Alport syndrome 2, autosomal recessive | ATS2 | 203780 | SEQ, MLPA, NGS | C | Syndro | |
COL4A5 | 303630 | Alport syndrome 1, X-linked | ATS1 | 301050 | SEQ, MLPA, NGS | C | Kidney | |
COL4A5 | 303630 | Alport syndrome 1, X-linked | ATS1 | 301050 | SEQ, MLPA, NGS | C | Syndro | |
COL5A1 | 120215 | Ehlers-Danlos syndrome, classic type 1 | EDSCL1 | 130000 | SEQ, MLPA, NGS | C | Tissue | |
COL5A2 | 120190 | Ehlers-Danlos syndrome, classic type 2 | EDSCL2 | 130010 | SEQ, NGS | C | Tissue | |
COL9A2 | 120260 | Epiphyseal dysplasia, multiple, 2 | EDM2 | 600204 | SEQ, NGS | C | Tissue | |
COL9A2 | 120260 | Stickler syndrome type 5, autosomal recessive | STL5 | 614284 | SEQ, NGS | C | Tissue | |
COL9A3 c.280C>T, c.307C>T | 120270 | Intervertebral disc disease | IDD | 603932 | SEQ | C | Tissue | |
CPS1 | 608307 | Carbamoylphosphate synthetase I deficiency | CPS1 deficiency | 237300 | SEQ, NGS | C | Meta | |
CPS1 | 608307 | Carbamoylphosphate synthetase I deficiency | CPS1 deficiency | 237300 | SEQ, NGS | C | Path | |
CTRC | 601405 | Hereditary pancreatitis | PCTT | 167800 | SEQ, NGS | C | Tumor | |
CXORF5 | 300170 | Orofaciodigital syndrome type 1 | OFD I | 311200 | SEQ, NGS | C | Syndro | |
CYB5A | 613218 | Methemoglobinemia type 4 | 250790 | SEQ, NGS | C | Coagul | ||
CYB5R3 | 613213 | Methemoglobinemia, type 1 and 2 | Methemoglobinemia due to deficiency of methemoglobin reductase | 250800 | SEQ, NGS | C | Coagul | |
CYP21A2 | 613815 | Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency | 201910 | SEQ, MLPA, NGS | C | Meta | ||
CYP4V2 | 608614 | Bietti crystalline corneoretinal dystrophy | BCD | 210370 | SEQ, NGS | C | Sensory | |
CYP7B1 | 603711 | Spastic paraplegia type 5 A, autosomal recessive | SPG5A | 270800 | SEQ, MLPA, NGS | C | Neuro | |
DCX | 300121 | Lissencephaly, X-linked | LISX1 | 300067 | SEQ, MLPA, NGS | D | Syndro | |
DCX | 300121 | Subcortical laminar heterotopia, X-linked | SCLH | 300067 | SEQ, MLPA, NGS | D | Syndro | |
DDC | AADC | 107930 | Aromatic L-amino acid decarboxylase deficiency | AADCD, dopa decarboxylase deficiency | 608643 | SEQ, NGS | D | Neuro |
del10p13-14 | DiGeorge syndrome / velocardiofacial syndrome complex-2 | 601362 | MLPA | # | Micro | |||
del11p13 (PAX6, WT1 genes) | 607108, 607102 | Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome | WAGR syndrome, chromosome 11p13 deletion syndrome | 194072 | MLPA | # | Micro | |
del11q23 | Jacobsen syndrome | chromosome 11q deletion syndrome | 147791 | MLPA | # | Micro | ||
del17p11.2 (RAI1 gene) | 607642 | Smith-Magenis syndrome | 182290 | MLPA | # | Micro | ||
del17p13.3 (LIS1 gene) | Miller-Dieker lissencephaly syndrome | MDLS | 247200 | MLPA | # | Micro | ||
del22q11.2 | DiGeorge syndrome | 188400 | MLPA | # | Micro | |||
del22q11.2 | Velocardiofacial syndrome | 192430 | MLPA | # | Micro | |||
del7q11.23 | Williams-Beuren syndrome | 194050 | MLPA | # | Micro | |||
del8q24.11-q24.13 (TRPS1, EXT1 genes) | 604386, 608177 | Langer-Giedion syndrome | trichorhinophalangeal syndrome, type II | 150230 | MLPA | # | Micro | |
DHCR7 | 602858 | Smith-Lemli-Opitz syndrome | SLOS | 270400 | SEQ, MLPA, NGS | D | Syndro | |
DLL3 | 602768 | Spondylocostal dysostosis-1, autosomal recessive | SCDO1 | 277300 | SEQ, NGS | D | Tissue | |
DMD | 300377 | Becker muscular dystrophy | BMD | 300376 | SEQ, MLPA, NGS | D | Neuro | |
DMD | 300377 | Duchenne muscular dystrophy | DMD | 310200 | SEQ, MLPA, NGS | D | Neuro | |
DNM2 | 602378 | Charcot-Marie-Tooth neuropathy, axonal, type 2M | CMT2M | 606482 | SEQ, NGS | D | Neuro | |
DNM2 | 602378 | Charcot-Marie-Tooth neuropathy, dominant intermediate, type B | CMTDIB | 606482 | SEQ, NGS | D | Neuro | |
DNM2 | 602378 | Myotubular myopathy/ centronuclear myopathy, autosomal dominant | CNM1 | 160150 | SEQ, NGS | D | Neuro | |
DPYD exons 11, 13, 14 and 22 | 612779 | Dihydropyrimidine dehydrogenase deficiency | 274270 | SEQ | D | Meta | ||
DPYD, exons 11, 13, 14 and 22 | 612779 | 5-fluorouracil toxicity | 274270 | SEQ | D | Pharma | ||
DPYS | 613326 | Dihydropyrimidinase deficiency | DPYSD, Dihydropyrimidinuria | 222748 | SEQ, NGS | D | Meta | |
dup17p11.2 (RAI1 gene) | 607642 | Potocki-Lupski syndrome | PTLS | 610883 | MLPA | # | Micro | |
DYSF | 603009 | Miyoshi muscular dystrophy 1 | MMD1 | 254130 | SEQ, MLPA, NGS | D | Neuro | |
DYSF | 603009 | Muscular dystrophy, limb-girdle, type 2B | LGMD2B | 253601 | SEQ, MLPA, NGS | D | Neuro | |
EDN3 | 131242 | Hirschsprung disease type 4 | HSCR4 | 613712 | SEQ, MLPA, NGS | E | Syndro | |
EDN3 | 131242 | Waardenburg syndrome, type 4B | WS4B | 613265 | SEQ, MLPA, NGS | E | Syndro | |
EDNRB | 131244 | ABCD syndrome | ABCDS, albinism, black lock, cell migration disorder of the neurocytes of the gut, and deafness | 600501 | SEQ, MLPA, NGS | E | Syndro | |
EDNRB | 131244 | Hirschsprung disease type 2 | HSCR2 | 600155 | SEQ, MLPA, NGS | E | Syndro | |
EDNRB | 131244 | Waardenburg syndrome, type 4A | WS4A | 277580 | SEQ, MLPA, NGS | E | Syndro | |
EGR2 | 129010 | Charcot-Marie-Tooth neuropathy type 1D | CMT1D, HMSN1D | 607678 | SEQ, MLPA, NGS | E | Neuro | |
EHMT1 | 607001 | Kleefstra syndrome | 610253 | SEQ, MLPA, NGS | E | Syndro | ||
EIF2B2 | 606454 | Leukoencephalopathy with vanishing white matter | VWM | 603896 | SEQ, NGS | E | Neuro | |
EIF2B2 | 606454 | Ovarioleukodystrophy | Vanishing white matter leukodystrophy with ovarian failure | 603896 | SEQ, NGS | E | Neuro | |
EIF2B5 | 603945 | Leukoencephalopathy with vanishing white matter | VWM | 603896 | SEQ, NGS | E | Neuro | |
EIF2B5 | 603945 | Ovarioleukodystrophy | Vanishing white matter leukodystrophy with ovarian failure | 603896 | SEQ, NGS | E | Neuro | |
EMD | 300384 | Emery-Dreifuss muscular dystrophy type 1, X-linked | EDMD1 | 310300 | SEQ, NGS | E | Neuro | |
ENG | 131195 | Telangiectasia, hereditary hemorrhagic, type 1 | HHT1, Osler-Rendu-Weber disease type 1 | 187300 | SEQ, MLPA, NGS | E | Tissue | |
ERCC2 | 126340 | Cerebrooculofacioskeletal syndrome type 2 | COFS2 | 610756 | SEQ, NGS | E | Syndro | |
ERCC2 | 126340 | Trichothiodystrophy, photosensitive | TTDP | 601675 | SEQ, NGS | E | Geno | |
ERCC2 | 126340 | Xeroderma pigmentosum, group D | XPG | 278730 | SEQ, NGS | E | Geno | |
ERCC5 | 133530 | Cerebrooculofacioskeletal syndrome type 3 | COFS3 | 616570 | SEQ, NGS | E | Syndro | |
ERCC5 | 133530 | Xeroderma pigmentosum, group G | XPG | 278780 | SEQ, NGS | E | Geno | |
ERCC6 | 609413 | Cerebrooculofacioskeletal syndrome type 1 | COFS1, Pena-Shokeir syndrome type 2 | 214150 | SEQ, NGS | E | Syndro | |
ERCC6 | 609413 | Cockayne syndrome, type B | CSB | 133540 | SEQ, NGS | E | Syndro | |
ERCC6 | 609413 | De Sanctis-Cacchione syndrome | 278800 | SEQ, NGS | E | Syndro | ||
ERCC8 | 609412 | Cockayne syndrome, type A | CSA | 216400 | SEQ, NGS | E | Syndro | |
ERCC8 | 609412 | UV-sensitive syndrome type 2 | UVSS2 | 614621 | SEQ, NGS | E | Syndro | |
EXT1 | 608177 | Exostoses, multiple, type 1 | multiple hereditary exostoses type 1 | 133700 | SEQ, MLPA, NGS | E | Tissue | |
EXT2 | 608210 | Exostoses, multiple, type 2 | multiple hereditary exostoses type 2 | 133701 | SEQ, MLPA, NGS | E | Tissue | |
EZH2 | 601573 | Weaver syndrome | Weaver-Smith syndrome | 277590 | SEQ, NGS | E | Syndro | |
F11 | 264900 | Factor XI deficiency | Hemophilia C, plasma thromboplastin antecedent | 612416 | SEQ, MLPA, NGS | F | Coagul | |
F12 | 610619 | Angioedema, hereditary, type III | HAE3 | 610618 | SEQ, MLPA, NGS | F | Meta | |
F12 | 610619 | Factor XII deficiency | Hageman factor deficiency | 234000 | SEQ, MLPA, NGS | F | Coagul | |
F2 G20210A | Factor II | 176930 | Factor II defect | Prothrombin | 188050 | SEQ | F | Coagul |
F5 FVL mutation | Factor V | 612309 | Factor V deficiency | Factor V Leiden mutation | 188055 | SEQ | F | Coagul |
F7 | Factor VII | 613878 | Factor VII deficiency | Hypoproconvertinemia | 227500 | SEQ, MLPA, NGS | F | Coagul |
F9 | Factor IX | 300746 | Factor IX deficiency | Hemophilia B, Christmas disease | 306900 | SEQ, MLPA, NGS | F | Coagul |
FAM20C | 611061 | Raine syndrome | RNS, osteosclerotic bone dysplasia, lethal | 259775 | SEQ, NGS | F | Syndro | |
FAM20C | 611061 | Raine syndrome | RNS, osteosclerotic bone dysplasia, lethal | 259775 | SEQ, NGS | F | Tissue | |
FBN1 | 134797 | Marfan syndrome | MFS, MFS1 | 154700 | SEQ, MLPA, NGS | F | Tissue | |
FBN2 exons 8, 9, 17, 24 – 35 | 612570 | Contractural arachnodactyly, congenital | CCA, Beals syndrome, Beals-Hecht syndrome | 121050 | SEQ | F | Tissue | |
FGFR1 | 136350 | Jackson-Weiss syndrome | Craniosynostosis, midfacial hypoplasia, and foot abnormalities | 123150 | SEQ, MLPA, NGS | F | Syndro | |
FGFR1 | 136350 | Kallmann syndrome 2 | Hypogonadotropic hypogonadism 2 with or without anosmia | 147950 | SEQ, MLPA, NGS | F | Syndro | |
FGFR1 p.Pro252Arg | 136350 | Pfeiffer syndrome | FGFR1 136350 p.Pro252Arg | 101600 | SEQ | F | Syndro | |
FGFR2 | 176943 | Apert syndrome | Acrocephalosyndactyly type 1 | 101200 | SEQ, MLPA, NGS | F | Syndro | |
FGFR2 | 176943 | Beare-Stevenson syndrome | BSTVS | 123790 | SEQ, MLPA, NGS | F | Syndro | |
FGFR2 | 176943 | Crouzon syndrome | Craniofacial dysostosis, type 1, CFD1 | 123500 | SEQ, MLPA, NGS | F | Syndro | |
FGFR2 | 176943 | Pfeiffer syndrome | 101600 | SEQ, MLPA, NGS | F | Syndro | ||
FGFR3 | 134934 | Achondroplasia | ACH | 100800 | SEQ, MLPA, NGS | F | Tissue | |
FGFR3 | 134934 | Hypochondroplasia | HCH | 146000 | SEQ, MLPA, NGS | F | Tissue | |
FGFR3 | 134934 | Thanatophoric dysplasia type I | TD1 | 187600 | SEQ, MLPA, NGS | F | Tissue | |
FGFR3 | 134934 | Thanatophoric dysplasia type II | TD2 | 187601 | SEQ, MLPA, NGS | F | Tissue | |
FGFR3 mutation p.Ala391Glu | 134934 | Crouzon syndrome with acanthosis nigricans | CAN | 612247 | SEQ | F | Syndro | |
FGFR3 mutation p.Arg621His | 134934 | Camptodactyly, tall stature and hearing loss | CATSHL syndrome | 610474 | SEQ | F | Syndro | |
FGFR3 mutation p.Pro250Arg | 134934 | Muenke syndrome | MNKES | 602849 | SEQ | F | Syndro | |
FH | 136850 | Fumarase deficiency | Fumaric aciduria | 606812 | SEQ, MLPA, NGS | F | Meta | |
FH | 136850 | Hereditary leiomyomatosis and renal cell cancer | HLRCC | 150800 | SEQ, MLPA, NGS | F | Tumor | |
FH | 136850 | Hereditary leiomyomatosis and renal cell cancer | HLRCC | 150800 | SEQ, MLPA, NGS | F | Kidney | |
FHL1 | 300163 | Emery-Dreifuss muscular dystrophy type 6, X-linked Typ 6 | EDMD6 | 300696 | SEQ, NGS | F | Neuro | |
FHL1 | 300163 | X-linked reducing body myopathy-1 with infantile or early childhood onset | RBMX1A | 300717 | SEQ, NGS | F | Neuro | |
FHL1 | 300163 | X-linked reducing body myopathy-1 with late childhood or adult onset | RBMX1B | 300718 | SEQ, NGS | F | Neuro | |
FIG4 | 609390 | Amyotrophic lateral sclerosis type 11 | ALS11 | 612577 | SEQ, NGS | F | Neuro | |
FIG4 | 609390 | Charcot-Marie-Tooth neuropathy type 4J | CMT4J | 611228 | SEQ, NGS | F | Neuro | |
FKBP10 | FK506 | 607063 | Osteogenesis imperfecta, type XI | OI11 | 610968 | SEQ, NGS | F | Tissue |
FKRP | 606596 | Muscular dystrophy, congenital, 1C | MDC1C | 606612 | SEQ, MLPA, NGS | F | Neuro | |
FKRP | 606596 | Muscular dystrophy, limb-girdle, type 2I | LGMD2I | 607155 | SEQ, MLPA, NGS | F | Neuro | |
FLCN | 607273 | Birt-Hogg-Dubé syndrome | BHD | 135150 | SEQ, MLPA, NGS | F | Neuro | |
FOXC1 | 601090 | Anterior segment dysgenesis, type 3 | ASGD3 | 601631 | SEQ, MLPA, NGS | F | Sensory | |
FOXC1 | 601090 | Axenfeld-Rieger syndrome type 3 | RIEG3 | 602482 | SEQ, MLPA, NGS | F | Sensory | |
FOXG1 | 164874 | Rett syndrome, congenital variant | 613454 | SEQ, MLPA, NGS | F | Syndro | ||
FOXL2 | 605597 | Blepharophimosis, epicanthus inversus, and ptosis type 1 and 2 | BPES | 110100 | SEQ, MLPA, NGS | F | Syndro | |
FOXL2 | 605597 | Premature ovarian failure type 3 | POF3 | 608996 | SEQ, MLPA, NGS | F | Syndro | |
FTL | 134790 | Hyperferritinemia-cataract syndrome | 600886 | SEQ, NGS | F | Meta | ||
FTL | 134790 | Hyperferritinemia-cataract syndrome | 600886 | SEQ, NGS | F | Sensory | ||
FTL | 134790 | Hyperferritinemia-cataract syndrome | 600886 | SEQ, NGS | F | Syndro | ||
FTL | 134790 | L-Ferritin deficiency | LFTD | 615604 | SEQ, NGS | F | Meta | |
FTL | 134790 | Neurodegeneration with brain iron accumulation, type 3 | NBIA3 | 606159 | SEQ, NGS | F | Neuro | |
FUS | 137070 | Amyotrophic lateral sclerosis type 6, with or without frontotemporal dementia | ALS6 | 608030 | SEQ, NGS | F | Neuro | |
FUS | 137070 | Tremor, hereditary essential type 4 | ETM4 | 614782 | SEQ, NGS | F | Neuro | |
FXN repeat | 606829 | Friedreich ataxia | Friedreich disease, FRDA | 229300 | REP | F | Neuro | |
GALT | 606999 | Galactosemia | GALAC1 | 230400 | SEQ, MLPA, NGS | G | Meta | |
GAN | 605379 | Neuropathy with giant axonal swelling, type 1 | Giant Axonal Neuropathy 1, GAN1 | 256850 | SEQ, NGS | G | Neuro | |
GANAB | 104160 | Polycystic kidney disease type 3 | PKD3 | 600666 | SEQ, NGS | G | Kidney | |
GANAB | 104160 | Polycystic kidney disease type 3 | PKD3 | 600666 | SEQ, NGS | G | Syndro | |
GARS1 | GARS | 600287 | Charcot-Marie-Tooth neuropathy type 2D | CMT2D, HMSN2D | 601472 | SEQ, MLPA, NGS | G | Neuro |
GATA5 | 611496 | Congenital heart defects, multiple types, 5 | 617912 | SEQ, NGS | G | Tissue | ||
GBE1 | 607839 | Glycogen storage disease IV | GSD4, Andersen disease | 232500 | SEQ, NGS | G | Meta | |
GCH1 | DYT5A | 600225 | DOPA-responsive dystonia, autosomal dominant | DRD, Segawa syndrome | 128230 | SEQ, MLPA, NGS | G | Neuro |
GCK | 138079 | Hyperinsulinemic hypoglycemia, familial, type 3 | HHF3, hyperinsulinism, familial type 3 | 602485 | SEQ, MLPA, NGS | G | Meta | |
GCK | 138079 | Maturity-onset diabetes of the young, type 2 | MODY2 | 125851 | SEQ, MLPA, NGS | G | Meta | |
GDAP1 | 606598 | Charcot-Marie-Tooth neuropathy type 4A | CMT4A | 214400 | SEQ, MLPA, NGS | G | Neuro | |
GDAP1 | 606598 | Charcot-Marie-Tooth neuropathy, axonal, type 2K | CMT2K | 607831 | SEQ, MLPA, NGS | G | Neuro | |
GDAP1 | 606598 | Charcot-Marie-Tooth neuropathy, axonal, with vocal cord paresis | 607706 | SEQ, MLPA, NGS | G | Neuro | ||
GDF2 | 605120 | Telangiectasia, hereditary hemorrhagic, type 5 | HHT5 | 615506 | SEQ, NGS | G | Tissue | |
GDF3 | 606522 | Klippel-Feil syndrome 3, autosomal dominant | KFS3 | 613702 | SEQ, NGS | G | Syndro | |
GDF3 | 606522 | Microphthalmia with coloboma 6 | MCOPCB6 | 613703 | SEQ, NGS | G | Syndro | |
GDF3 | 606522 | Microphthalmia, isolated 7 | MCOP7 | 613704 | SEQ, NGS | G | Syndro | |
GDF5 | 601146 | Acromesomelic dysplasia, Hunter-Thompson type | AMDH | 201250 | SEQ, NGS | G | Tissue | |
GDF5 | 601146 | Brachydactyly, type C | BDC, Haws type | 113100 | SEQ, NGS | G | Tissue | |
GDF5 | 601146 | Chondrodysplasia, Grebe type | 200700 | SEQ, NGS | G | Tissue | ||
GDF5 | 601146 | Du Pan syndrome | fibular hypoplasia and complex brachydactyly | 228900 | SEQ, NGS | G | Tissue | |
GDF6 | 601147 | Klippel-Feil syndrome 1, autosomal dominant | KFS1 | 118100 | SEQ, NGS | G | Syndro | |
GDF6 | 601147 | Leber congenital amaurosis type 17 | LCA17 | 615360 | SEQ, NGS | G | Sensory | |
GDF6 | 601147 | Microphthalmia, isolated 4 | MCOP4 | 613094 | SEQ, NGS | G | Syndro | |
GFAP | 137780 | Alexander disease | 203450 | SEQ, NGS | G | Neuro | ||
GJB1 | Connexin 32 | 304040 | Charcot-Marie-Tooth neuropathy type X | CMTX, HMSNX | 302800 | SEQ, MLPA, NGS | G | Neuro |
GJB2 | Connexin 26 | 121011 | Deafness, autosomal recessive, type 1A | DFNB1A | 220290 | SEQ, MLPA, NGS | G | Sensory |
GJB3 | Connexin 31 | 603324 | Deafness, autosomal dominant, type 2B | DFNA2B | 612644 | SEQ, MLPA, NGS | G | Sensory |
GJB6, only CNV | Connexin 30 | 604418 | Deafness, autosomal recessive, type 1B | DFNB1B | 612645 | MLPA | G | Sensory |
GLA | 300644 | Fabry disease | 301500 | SEQ, MLPA, NGS | G | Meta | ||
GLI3 | 165240 | Greig cephalopolysyndactyly syndrome | Polysyndactyly with peculiar skull shape | 175700 | SEQ, NGS | G | Syndro | |
GLI3 | 165240 | Pallister-Hall syndrome | hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postaxial polydactyly | 146510 | SEQ, NGS | G | Syndro | |
GLI3 | 165240 | Postaxial polydactyly type A1 and type B | PAPA1 (PAPB included) | 174200 | SEQ, NGS | G | Syndro | |
GLI3 | 165240 | Preaxial polydactyly type IV | Polysyndactyly, uncomplicated | 174700 | SEQ, NGS | G | Syndro | |
GLMN | 601749 | Glomuvenous malformations | glomangiomas | 138000 | SEQ, NGS | G | Tumor | |
GLUD1 | 138130 | Hyperinsulinemic hypoglycemia, familial, type 6 | HHF6, Hyperinsulinism-hyperammonemia syndrome | 606762 | SEQ, NGS | G | Meta | |
GLUD1 | 138130 | Hyperinsulinemic hypoglycemia, familial, type 6 | HHF6, Hyperinsulinism-hyperammonemia syndrome | 606762 | SEQ, NGS | G | Path | |
GNAS | 139320 | Albright hereditary osteodystrophy, Pseudohypoparathyroidism type Ia | PHP1A | 103580 | SEQ, MLPA, NGS | G | Tissue | |
GNAS | 139320 | Osseous heteroplasia, progressive | POH | 166350 | SEQ, MLPA, NGS | G | Tissue | |
GNAS | 139320 | Pseudohypoparathyroidism type 1A | PHP1A | 103580 | SEQ, MLPA, NGS | G | Meta | |
GNAS | 139320 | Pseudohypoparathyroidism type 1B | PHP1B | 603233 | SEQ, MLPA, NGS | G | Meta | |
GNAS | 139320 | Pseudohypoparathyroidism type 1C | PHP1C | 612462 | SEQ, MLPA, NGS | G | Meta | |
GNAS | 139320 | Pseudopseudohypoparathyroidism | PPHP | 612463 | SEQ, MLPA, NGS | G | Meta | |
GNAS somatic mutations | 139320 | ACTH-independent macronodular adrenal hyperplasia | AIMAH1 | 219080 | SEQ, MLPA, NGS | G | Kidney | |
GNAS somatic mutations | 139320 | ACTH-independent macronodular adrenal hyperplasia | AIMAH1 | 219080 | SEQ, MLPA, NGS | G | Tumor | |
GNRH1 | 152760 | Hypogonadotropic hypogonadism with or without anosmia 12 | HH12 | 614841 | SEQ, MLPA, NGS | G | Syndro | |
GNRHR | 138850 | Hypogonadotropic hypogonadism with or without anosmia 7 | HH7, idiopathic hypogonadotropic hypogonadism | 146110 | SEQ, MLPA, NGS | G | Syndro | |
GNS | 607664 | Mucopolysaccharidosis type IIID, Sanfilippo syndrome D | MPS IIID | 252940 | SEQ, NGS | G | Meta | |
GPD1L | 611778 | Brugada syndrome type 2 | BRGDA2 | 611777 | SEQ, NGS | G | Cardio | |
GPR143 | OA1 gene | 300808 | Ocular albinism, type 1 | OA1, Nettleship-Falls type | 300500 | SEQ, MLPA, NGS | G | Meta |
GREM1 only CNV-analysis | 603054 | Hereditary mixed polyposis syndrome type 1 | HMPS1 | 601228 | MLPA, NGS | G | Tumor | |
GRHL3 | 608317 | Van der Woude syndrome type 2 | VWS2 | 606713 | SEQ, MLPA, NGS | G | Syndro | |
GRN | PGRN | 138945 | Aphasia, primary progressive | PPA | 607485 | SEQ, MLPA, NGS | G | Neuro |
GRN | PGRN | 138945 | Frontotemporal lobar degeneration with TDP43 inclusions | FTLD-TDP, Frontotemporal dementia, ubiquitin-positive, FTDU | 607485 | SEQ, MLPA, NGS | G | Neuro |
HADH | 601609 | 3-hydroxyacyl-CoA dehydrogenase deficiency | HADH Deficiency | 231530 | SEQ, NGS | H | Meta | |
HADH | 601609 | Hyperinsulinemic hypoglycemia, familial, type 4 | HHF4, hyperinsulinism, familial type 4 | 609975 | SEQ, NGS | H | Meta | |
HADHA | 600890 | Mitochondrial trifunctional protein deficiency | MTPD | 609015 | SEQ, NGS | H | Meta | |
HBB | 141900 | Sickle cell anemia | HBS | 603903 | SEQ, MLPA, NGS | H | Coagul | |
HBB | 141900 | Thalassemia, beta | beta hemoglobinopathy | 613985 | SEQ, MLPA, NGS | H | Coagul | |
HCN4 | 605206 | Brugada syndrome type 8 | BRGDA8 | 613123 | SEQ, NGS | H | Cardio | |
HCN4 | 605206 | Sick sinus syndrome 2 | SSS2, autosomal dominant | 163800 | SEQ, NGS | H | Cardio | |
HCRT | 602358 | Narcolepsy type 1 | NRCLP1 | 161400 | SEQ, NGS | H | Neuro | |
HEXA | 606869 | Tay-Sachs disease | 272800 | SEQ, MLPA, NGS | H | Meta | ||
HFE exon 2 and exon 4 | 613609 | Hemochromatosis | 235200 | SEQ | H | Meta | ||
HGSNAT | 610453 | Mucopolysaccharidosis type IIIC, Sanfilippo syndrome C | MPS IIIC | 252930 | SEQ, NGS | H | Meta | |
HGSNAT | 610453 | Retinitis pigmentosa 73 | RP73 | 616544 | SEQ, NGS | H | Sensory | |
HLA-B27 | 142830 | Spondyloarthropathy, susceptibility to, 1, | SPDA1, Bechterew syndrome | 106300 | SEQ | H | Meta | |
HLA-DQA1 and-DQB1, analysis of risk-alleles encoding HLA-DQ2 and -DQ8 only | 146880, 604305 | Celiac disease, susceptibility | 212750 | SEQ | H | Meta | ||
HLA-DQB1*0602 allele | 604305 | Narcolepsy, association | 161400 | SEQ | H | Neuro | ||
HMBS | 609806 | Porphyria, acute intermittent | AIP | 176000 | SEQ, MLPA, NGS | H | Meta | |
HMBS | 609806 | Porphyria, acute intermittent, nonerythroid variant | AIP | 176000 | SEQ, MLPA, NGS | H | Meta | |
HNF1A | TCF1 | 142410 | Maturity-onset diabetes of the young, type 3 | MODY3 | 600496 | SEQ, MLPA, NGS | H | Meta |
HNF1B | TCF2 | 189907 | Maturity-onset diabetes of the young, type 5 | MODY5 | 137920 | SEQ, MLPA, NGS | H | Meta |
HNF4A | 600281 | Maturity-onset diabetes of the young, type 1 | MODY1 | 125850 | SEQ, MLPA, NGS | H | Meta | |
HOXD13 | 142989 | Brachydactyly, type D | BDD | 113200 | SEQ, MLPA, NGS | H | Tissue | |
HOXD13 | 142989 | Brachydactyly, type E | BDE1 | 113300 | SEQ, MLPA, NGS | H | Tissue | |
HOXD13 | 142989 | Brachydactyly-syndactyly syndrome | Zhao type, BDSD | 610713 | SEQ, MLPA, NGS | H | Tissue | |
HOXD13 | 142989 | Syndactyly type V | Syndactyly with metacarpal and metatarsal fusion | 186300 | SEQ, MLPA, NGS | H | Tissue | |
HOXD13 | 142989 | Synpolydactyly type I | SPD1, syndactyly type II according to Temtamy and McKusick [PMID: 215242] | 186000 | SEQ, MLPA, NGS | H | Tissue | |
HOXD13 | 142989 | Synpolydactyly with anomalies of the foot | 186000 | SEQ, MLPA, NGS | H | Tissue | ||
HPRT1 | 308000 | Kelley-Seegmiller syndrome | HPRT-related gout/hyperuricemia | 300323 | SEQ, MLPA, NGS | H | Meta | |
HPRT1 | 308000 | Lesch-Nyhan syndrome | 300322 | SEQ, MLPA, NGS | H | Meta | ||
HRAS | 190020 | Costello syndrome | Faciocutaneoskeletal (FCS) syndrome | 218040 | SEQ, NGS | H | Syndro | |
HSD3B2 | 613890 | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | 3-beta-HSD deficiency, HSDB | 201810 | SEQ, NGS | H | Meta | |
HSPB1 | 602195 | Charcot-Marie-Tooth neuropathy, axonal, type 2F | CMT2F | 606595 | SEQ, MLPA, NGS | H | Neuro | |
HSPB1 | 602195 | Neuropathy, distal hereditary motor, type IIB | HMN2B | 608634 | SEQ, MLPA, NGS | H | Neuro | |
HSPB8 | 608014 | Charcot-Marie-Tooth neuropathy, axonal, type 2L | CMT2L | 608673 | SEQ, MLPA, NGS | H | Neuro | |
HSPB8 | 608014 | Neuropathy, distal hereditary motor, type IIA | HMN2A | 158590 | SEQ, MLPA, NGS | H | Neuro | |
HTR1A promoter mutation -480delA | 109760 | Periodic fever, menstrual cycle-dependent | PMFC | 614674 | SEQ | H | Fever | |
HTRA1 | 602194 | cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | CADASIL2 | 616779 | SEQ, NGS | H | Neuro | |
HTRA1 | 602194 | cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy | CARASIL , Maeda syndrome | 600142 | SEQ, NGS | H | Neuro | |
HTT repeat | 613004 | Huntington disease | HD, Huntington chorea | 143100 | REP | H | Neuro | |
ICOS | 604558 | Immunodeficiency, common variable, type 1 | CVID1, antibody deficiency due to icos defect | 607594 | SEQ, NGS | I | Meta | |
IDUA | 252800 | Mucopolysaccharidosis type IH, Hurler syndrome | MPS1-H | 607014 | SEQ, NGS | I | Meta | |
IDUA | 252800 | Mucopolysaccharidosis type IH/S, Hurler-Scheie syndrome | MPS1-H/S | 607015 | SEQ, NGS | I | Meta | |
IDUA | 252800 | Mucopolysaccharidosis type IS, Scheie syndrome | MPS1-S | 607016 | SEQ, NGS | I | Meta | |
IHH | 600726 | Brachydactyly, type A1 | Farabee brachydactyly | 112500 | SEQ, NGS | I | Tissue | |
IRF6 | 607199 | Popliteal pterygium syndrome | PPS | 119500 | SEQ, MLPA, NGS | I | Syndro | |
IRF6 | 607199 | Van der Woude syndrome type 1 | VWS1 | 119300 | SEQ, MLPA, NGS | I | Syndro | |
ITPR1 | 147265 | Gillespie syndrome | GLSP | 206700 | SEQ, MLPA, NGS | I | Neuro | |
ITPR1 | 147265 | Spinocerebellar ataxia type 15 | SCA15 | 606658 | SEQ, MLPA, NGS | I | Neuro | |
ITPR1 | 147265 | Spinocerebellar ataxia type 29 | SCA29 | 117360 | SEQ, MLPA, NGS | I | Neuro | |
JPH3 repeat | 605268 | Huntington disease-like 2 | HDL2 | 606438 | REP | J | Neuro | |
KCNA1 | 176260 | Episodic ataxia type 1 | Episodic ataxia with myokymia | 160120 | SEQ, MLPA, NGS | K | Neuro | |
KCND3 | 605411 | Brugada syndrome type 9 | BRGDA9 | 616399 | SEQ, NGS | K | Cardio | |
KCND3 | 605411 | Spinocerebellar ataxia type 19 | SCA19 | 607346 | SEQ, NGS | K | Neuro | |
KCNE1 | 176261 | Jervell and Lange-Nielsen syndrome type 2 | JLNS2 | 612347 | SEQ, MLPA, NGS | K | Cardio | |
KCNE1 | 176261 | Long QT syndrome 5 | LQT5 | 613695 | SEQ, MLPA, NGS | K | Cardio | |
KCNE2 | 603796 | Atrial fibrillation, familial, 4 | ATFB4 | 611493 | SEQ, MLPA, NGS | K | Cardio | |
KCNE2 | 603796 | Long QT syndrome 6 | LQT6 | 613693 | SEQ, MLPA, NGS | K | Cardio | |
KCNE3 | 604433 | Brugada syndrome type 6 | BRGDA6 | 613119 | SEQ, NGS | K | Cardio | |
KCNH2 | 152427 | Long QT syndrome 2 | LQT2, Romano-Ward syndrome 2 | 613688 | SEQ, MLPA, NGS | K | Cardio | |
KCNH2 | 152427 | Short QT syndrome 1 | SQT1 | 609620 | SEQ, MLPA, NGS | K | Cardio | |
KCNJ11 | Kir6.2 | 600937 | Hyperinsulinemic hypoglycemia, familial, type 2 | HHF2, hyperinsulinism, familial type 2 | 601820 | SEQ, NGS | K | Meta |
KCNJ18 | 613236 | Thyrotoxic periodic paralysis type 2 | TTPP2 | 613239 | SEQ, NGS | K | Neuro | |
KCNJ2 | 600681 | Andersen-Tawil syndrome | ATS, LQT7, periodic paralysis + ventricular arrhythmias + distinctive dysmorphic facial or skeletal features | 170390 | SEQ, MLPA, NGS | K | Cardio | |
KCNJ2 | 600681 | Long QT syndrome 7 | LQT7, Anderson-Tawil syndrome | 170390 | SEQ, MLPA, NGS | K | Cardio | |
KCNJ2 | 600681 | Short QT syndrome 3 | SQT3 | 609622 | SEQ, MLPA, NGS | K | Cardio | |
KCNQ1 | 607542 | Jervell and Lange-Nielsen syndrome type 1 | JLNS1, prolongation of the QT interval + congenital deafness | 220400 | SEQ, MLPA, NGS | K | Cardio | |
KCNQ1 | 607542 | Long QT syndrome 1 | LQT1, Romano-Ward syndrome 1 | 192500 | SEQ, MLPA, NGS | K | Cardio | |
KCNQ1 | 607542 | Short QT syndrome 2 | SQT2 | 609621 | SEQ, MLPA, NGS | K | Cardio | |
KCNV2 | 607604 | Retinal cone dystrophy type 3B | RCD3B | 610356 | SEQ, NGS | K | Sensory | |
KIF11 | 148760 | Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation | MCLMR | 152950 | SEQ, NGS | K | Syndro | |
KIF21A | 608283 | Congenital fibrosis of extraocular muscles type 1 | CFEOM1 | 135700 | SEQ, NGS | K | Sensory | |
KIF21A | 608283 | Congenital fibrosis of extraocular muscles type 3B | CFEOM3B | 135700 | SEQ, NGS | K | Sensory | |
KIF5A | 602821 | Spastic paraplegia type 10, autosomal dominant, | SPG10 | 604187 | SEQ, NGS | K | Neuro | |
KISS1R | 604161 | Hypogonadotropic hypogonadism with or without anosmia 8 | HH8 | 614837 | SEQ, MLPA, NGS | K | Syndro | |
KISS1R | 604161 | Precocious puberty, central, | CPPB1 | 176400 | SEQ, MLPA, NGS | K | Syndro | |
KLF1 | 600599 | Blood group-Lutheran inhibitor, dominant LU(a-b-) phenotype | INLU | 111150 | SEQ, NGS | K | Coagul | |
KLF1 | 600599 | Dyserythropoietic anemia, congenital, type IV | CDAN4 | 613673 | SEQ, NGS | K | Coagul | |
KLF1 | 600599 | Hereditary persistence of fetal hemoglobin type 6 | HBFQTL6 | 613566 | SEQ, NGS | K | Coagul | |
KRAS | 190070 | Cardiofaciocutaneous syndrome 2 | CFC2 | 615278 | SEQ, NGS | K | Syndro | |
KRAS | 190070 | Noonan syndrome 3 | NS3 | 609942 | SEQ, NGS | K | Syndro | |
L1CAM | 308840 | CRASH syndrome | Corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraplegia, and hydrocephalus | 303350 | SEQ, MLPA, NGS | L | Syndro | |
L1CAM | 308840 | Hydrocephalus, X-linked | Hydrocephalus due to congenital stenosis of aqueduct of sylvius | 307000 | SEQ, MLPA, NGS | L | Syndro | |
L1CAM | 308840 | Mental retardation, aphasia, shuffling gait, and adducted thumbs | MASA syndrome | 303350 | SEQ, MLPA, NGS | L | Syndro | |
L1CAM | 308840 | Spastic paraplegia type 1, X-linked, | SPG1 | 303350 | SEQ, MLPA, NGS | L | Neuro | |
LCT c.1-13910T/C | 603202 | Lactose intolerance | 223100 | SEQ | L | Meta | ||
LCT complete gene | 603202 | Lactase deficiency, congenital | alactasia, congenital | 223000 | SEQ, MLPA, NGS | L | Meta | |
LDLR | 606945 | Hypercholesterolemia, familial, type 1 | FHCL1, Hyperlipoproteinemia, type IIA | 143890 | SEQ, MLPA, NGS | L | Meta | |
LDLRAP1 | 605747 | Hypercholesterolemia, familial, type 4 | FHCL4, autosomal recessive | 603813 | SEQ, NGS | L | Meta | |
LEP | 164160 | Obesity, morbid, due to leptin deficiency | 614962 | SEQ, MLPA, NGS | L | Meta | ||
LEPR | 601007 | Obesity, morbid, due to leptin receptor deficiency | 614963 | SEQ, MLPA, NGS | L | Meta | ||
LITAF | 603795 | Charcot-Marie-Tooth neuropathy type 1C | CMT1C, HMSN1C | 601098 | SEQ, NGS | L | Neuro | |
LMNA | 150330 | Cardiomyopathy, dilated, 1A | CMD1A | 115200 | SEQ, MLPA, NGS | L | Cardio | |
LMNA | 150330 | Charcot-Marie-Tooth neuropathy type 2B1 | CMT2B1, HMSN2B1 | 605588 | SEQ, MLPA, NGS | L | Neuro | |
LMNA | Lamin-A/C | 150330 | Emery-Dreifuss muscular dystrophy type 2, autosomal dominant | 181350 | SEQ, MLPA, NGS | L | Neuro | |
LMNA | Lamin-A/C | 150330 | Emery-Dreifuss muscular dystrophy type 3, autosomal recessive | 616516 | SEQ, MLPA, NGS | L | Neuro | |
LMNA | 150330 | Hutchinson-Gilford progeria syndrome, childhood-onset | 176670 | SEQ, MLPA, NGS | L | Syndro | ||
LMNA | 150330 | Lipodystrophy, familial partial, type 2 | FPLD2, Lipodystrophy type Dunnigan | 151660 | SEQ, MLPA, NGS | L | Meta | |
LMNA | 150330 | Lipodystrophy, familial partial, type 2 | FPLD2, Lipodystrophy type Dunnigan | 151660 | SEQ, MLPA, NGS | L | Syndro | |
LMNA | 150330 | Mandibuloacral dysplasia with type a lipodystrophy | MADA | 248370 | SEQ, MLPA, NGS | L | Syndro | |
LMNA | 150330 | Muscular dystrophy, limb-girdle, type 1B | LGMD1B | 159001 | SEQ, MLPA, NGS | L | Neuro | |
LMNA | 150330 | Werner syndrome, atypical | SEQ, MLPA, NGS | L | Syndro | |||
LMNB2 | 150341 | Lipodystrophy, partial, acquired, susceptibility | APLD, Barraquer-Simons syndrome | 608709 | SEQ, NGS | L | Meta | |
LMX1B | NPS1 | 602575 | Nail-patella syndrome | NPS, Turner-Kieser syndrome, Fong disease | 161200 | SEQ, MLPA, NGS | L | Syndro |
LRP6 | 603507 | Coronary artery disease, autosomal dominant, 2 | ADCAD2 | 610947 | SEQ, NGS | L | Cardio | |
LRRK2 | 609007 | Parkinson disease, autosomal dominant, type 8 | PARK8 | 607060 | SEQ, MLPA, NGS | L | Neuro | |
LYST | CHS1 | 606897 | Chediak-Higashi syndrome | CHS | 214500 | SEQ, NGS | L | Syndro |
MAPT | 157140 | Frontotemporal dementia | FTD | 600274 | SEQ, MLPA, NGS | M | Neuro | |
MAPT | 157140 | Frontotemporal dementia with parkinsonism | Multiple system tauopathy with presenile dementia, FTD17 | 600274 | SEQ, MLPA, NGS | M | Neuro | |
MAPT | 157140 | Pick disease of brain | Dementia with lobar atrophy and neuronal cytoplasmic inclusions | 172700 | SEQ, MLPA, NGS | M | Neuro | |
MAT1A | 610550 | Methionine adenosyltransferase deficiency | Hypermethioninemia | 250850 | SEQ, NGS | M | Meta | |
MAX | 154950 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | M | Kidney | |
MAX | 154950 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | M | Tumor | |
MAX | 154950 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, MLPA, NGS | M | Tumor | ||
MAX | 154950 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, MLPA, NGS | M | Kidney | ||
MC4R | 155541 | Obesity | 601665 | SEQ, MLPA, NGS | M | Meta | ||
MECP2 | 300005 | Encephalopathy, neonatal severe | 300673 | SEQ, MLPA, NGS | M | Syndro | ||
MECP2 | 300005 | Mental retardation, X-linked syndromic, Lubs type | MRXSL | 300260 | SEQ, MLPA, NGS | M | Syndro | |
MECP2 | 300005 | Mental retardation, X-linked, syndromic 13 | MRX13 | 300055 | SEQ, MLPA, NGS | M | Syndro | |
MECP2 | 300005 | Rett syndrome | 312750 | SEQ, MLPA, NGS | M | Syndro | ||
MEFV | 608107 | Familial mediterranean fever, dominant or recessive | FMF, autosomal dominant /autosomal recessive | 134610 / 249100 | SEQ, MLPA, NGS | M | Fever | |
MEN1 | 613733 | Multiple endocrine neoplasia type 1 | MEN1 | 131100 | SEQ, MLPA, NGS | M | Tumor | |
MEOX1 | 600147 | Klippel-Feil syndrome 2, autosomal recessive | KFS2 | 214300 | SEQ, NGS | M | Syndro | |
MESP2 | 605195 | Spondylocostal dysostosis 2, autosomal recessive | SCDO2 | 608681 | SEQ, NGS | M | Tissue | |
MET | 64860 | Renal cell carcinoma, papillary, 1, familial and somatic | RCCP1 | 605074 | SEQ, NGS | M | Tumor | |
MET1 | 64860 | Renal cell carcinoma, papillary, 1, familial and somatic | RCCP1 | 605074 | SEQ, NGS | M | Kidney | |
MFAP5 | 601103 | Thoracic aortic aneurysm type 9 | AAT9 | 616166 | SEQ, NGS | M | Tissue | |
MFN2 | 608507 | Charcot-Marie-Tooth neuropathy type 2A2 | CMT2A2, HMSN2A2 | 609260 | SEQ, MLPA, NGS | M | Neuro | |
MITF | 156845 | Tietz albinism-deafness syndrome | 103500 | SEQ, MLPA, NGS | M | Syndro | ||
MITF | 156845 | Waardenburg syndrome type 2A | WS2A | 193510 | SEQ, MLPA, NGS | M | Syndro | |
MLH1 | 120436 | Hereditary nonpolyposis colorectal cancer type II | HNPCC, Lynch syndrome | 609310 | SEQ, MLPA, NGS | M | Tumor | |
MNX1 | 142994 | Currarino syndrom | 176450 | SEQ, NGS | M | Syndro | ||
MOG | 159465 | Narcolepsy type 7 | NRCLP7 | 614250 | SEQ, NGS | M | Neuro | |
MPZ | P0 | 159440 | Charcot-Marie-Tooth neuropathy type 1B | CMT1B, HMSN1B | 118200 | SEQ, MLPA, NGS | M | Neuro |
MPZ | P0 | 159440 | Charcot-Marie-Tooth neuropathy type 2I | CMT2I, HMSN2I | 607677 | SEQ, MLPA, NGS | M | Neuro |
MPZ | P0 | 159440 | Charcot-Marie-Tooth neuropathy type 2J | CMT2J, HMSN2J | 607736 | SEQ, MLPA, NGS | M | Neuro |
MSH2 | 609309 | Hereditary nonpolyposis colorectal cancer type I | HNPCC, Lynch syndrome | 120435 | SEQ, MLPA, NGS | M | Tumor | |
MSH3 | 600887 | Familial adenomatous polyposis coli, familial polyposis of the colon, type 4 | FAP4 | 617100 | SEQ, NGS | M | Tumor | |
MSH6 | 600678 | Hereditary nonpolyposis colorectal cancer type V | HNPCC, Lynch syndrome | 614350 | SEQ, MLPA, NGS | M | Tumor | |
MSX1 | 142983 | Hypodontia/oligodontia type 1 | Tooth agenesis, selective, with or without orofacial cleft, STHAG1 | 106600 | SEQ, NGS | M | Syndro | |
MSX1 | 142983 | Orofacial cleft type 5 | 608874 | SEQ, NGS | M | Syndro | ||
MSX1 | 142983 | Witkop syndrome | Nail dysplasia with hypodontia | 189500 | SEQ, NGS | M | Syndro | |
MT-ATP6 | 516060 | Leber hereditary optic neuropathy | LHON | 535000 | SEQ, NGS | M | Sensory | |
MT-ATP6 | 516060 | Leigh syndrome | 256000 | SEQ, NGS | M | Neuro | ||
MT-ATP6 | 516060 | NARP | Neuropathy, Ataxia, retinitis pigmentosa | 551500 | SEQ, NGS | M | Neuro | |
MTHFR | 607093 | Methylenetetrahydrofolate reductase deficiency | Homocystinuria due to MTHFR deficiency | 236250 | SEQ, NGS | M | Meta | |
MTHFR c.677C>T and c.1298A>C | 607093 | Homocystinuria due to MTHFR deficiency | 236250 | SEQ | M | Coagul | ||
MTM1 | 300415 | Myotubular myopathy/ centronuclear myopathy, X-chromosomal-recessive | CNMX | 310400 | SEQ, NGS | M | Neuro | |
MTMR2 | 603557 | Charcot-Marie-Tooth neuropathy type 4B1 | CMT4B1 | 601382 | SEQ, MLPA, NGS | M | Neuro | |
MT-ND1 | 516000 | Leber hereditary optic neuropathy | LHON | 535000 | SEQ, NGS | M | Sensory | |
MT-ND1 | 516000 | Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | SEQ, NGS | M | Neuro | |
MT-ND3 | 516002 | Leber hereditary optic neuropathy | LHON | 535000 | SEQ, NGS | M | Sensory | |
MT-ND4 | 516003 | Leber hereditary optic neuropathy | LHON | 535000 | SEQ, NGS | M | Sensory | |
MT-ND4L | 516004 | Leber hereditary optic neuropathy | LHON | 535000 | SEQ, NGS | M | Sensory | |
MT-ND5 | 516005 | Leber hereditary optic neuropathy | LHON | 535000 | SEQ, NGS | M | Sensory | |
MT-ND5 | 516005 | Leigh syndrome | 256000 | SEQ, NGS | M | Neuro | ||
MT-ND5 | 516005 | Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | SEQ, NGS | M | Neuro | |
MT-ND5 | 516005 | Myoclonic epilepsy associated with ragged-red fibers | MERRF | 545000 | SEQ, NGS | M | Neuro | |
MT-ND6 | 516006 | Leber hereditary optic neuropathy | LHON | 535000 | SEQ, NGS | M | Sensory | |
MT-ND6 | 516006 | Leigh syndrome | 256000 | SEQ, NGS | M | Neuro | ||
MT-ND6 | 516006 | Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | SEQ, NGS | M | Neuro | |
MT-TH | 590040 | Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | SEQ, NGS | M | Neuro | |
MT-TH | 590040 | Myoclonic epilepsy associated with ragged-red fibers | MERRF | 545000 | SEQ, NGS | M | Neuro | |
MT-TK | 590060 | Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | SEQ, NGS | M | Neuro | |
MT-TK | 590060 | Myoclonic epilepsy associated with ragged-red fibers | MERRF | 545000 | SEQ, NGS | M | Neuro | |
MT-TL1 | 590050 | Leber hereditary optic neuropathy | LHON | 535000 | SEQ, NGS | M | Sensory | |
MT-TL1 | 590050 | Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | SEQ, NGS | M | Neuro | |
MT-TL1 | 590050 | Myoclonic epilepsy associated with ragged-red fibers | MERRF | 545000 | SEQ, NGS | M | Neuro | |
MTTP | MTP | 157147 | Abetalipoproteinemia | Acanthocytosis, Bassen-Kornzweig-syndrome | 200100 | SEQ, NGS | M | Neuro |
MT-TS2 | 590085 | Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes | MELAS | 540000 | SEQ, NGS | M | Neuro | |
MT-TS2 | 590085 | Myoclonic epilepsy associated with ragged-red fibers | MERRF | 545000 | SEQ, NGS | M | Neuro | |
MUTYH | 604933 | Attenuated familial adenomatous polyposis | AFAP | 175100 | SEQ, MLPA, NGS | M | Tumor | |
MUTYH | 604933 | MUTYH-associated polyposis | MAP | 608456 | SEQ, MLPA, NGS | M | Tumor | |
MVK | 251170 | Hyper-IgD syndrome | HIDS, hyperimmunoglobulinemia D and periodic fever, mevalonat kinase deficiency | 260920 | SEQ, NGS | M | Fever | |
MVK | 251170 | Mevalonic aciduria | MEVA | 610377 | SEQ, NGS | M | Meta | |
MVK | 251170 | Porokeratosis type 3, actinic disseminated superficial | POROK3 | 175900 | SEQ, NGS | M | Geno | |
MYBPC3 | 600958 | Cardiomyopathy, dilated, 1MM | CMD1MM | 615396 | SEQ, MLPA, NGS | M | Cardio | |
MYBPC3 | 600958 | Cardiomyopathy, familial hypertrophic 4 | CMH4 | 115197 | SEQ, MLPA, NGS | M | Cardio | |
MYH11 | 160745 | Thoracic aortic aneurysm type 4 | AAT4, FAA4 | 132900 | SEQ, MLPA, NGS | M | Tissue | |
MYH7 | 160760 | Cardiomyopathy, dilated, 1S | CMD1S | 613426 | SEQ, MLPA, NGS | M | Cardio | |
MYH7 | 160760 | Cardiomyopathy, familial hypertrophic 1 | CMH1 | 192600 | SEQ, MLPA, NGS | M | Cardio | |
MYL2 | 160781 | Cardiomyopathy, familial hypertrophic 10 | CMH10 | 608758 | SEQ, NGS | M | Cardio | |
MYL3 | 160790 | Cardiomyopathy, familial hypertrophic 8 | CMH8 | 608751 | SEQ, NGS | M | Cardio | |
MYLK | 600922 | Thoracic aortic aneurysm type 7 | AAT7 | 613780 | SEQ, NGS | M | Tissue | |
MYORG | 618255 | Basal ganglia calcification, idiopathic, 7, autosomal recessive | IBGC7 | 618317 | SEQ, NGS | M | Neuro | |
NAGLU | 609701 | Mucopolysaccharidosis type IIIB, Sanfilippo syndrome B | MPS IIIB | 252920 | SEQ, NGS | N | Meta | |
NAGS | 608300 | N-acetylglutamate synthase deficiency | NAGS deficiency | 237310 | SEQ, NGS | N | Meta | |
NAGS | 608300 | N-acetylglutamate synthase deficiency | NAGS deficiency | 237310 | SEQ, NGS | N | Path | |
NBN | NBS1 | 602667 | Nijmegen breakage syndrome | NBS | 251260 | SEQ, NGS | N | Tumor |
NEFL | NF68 | 162280 | Charcot-Marie-Tooth neuropathy type 1F | CMT1F, HMSN1F | 607734 | SEQ, MLPA, NGS | N | Neuro |
NEFL | NF68 | 162280 | Charcot-Marie-Tooth neuropathy type 2E | CMT2E, HMSN2E | 607684 | SEQ, MLPA, NGS | N | Neuro |
NF1 | 613113 | Neurofibromatosis type 1 | NF1 | 162200 | SEQ, MLPA, NGS | N | Tumor | |
NF2 | 607379 | Neurofibromatosis type 2 | NF2 | 101000 | SEQ, MLPA, NGS | N | Tumor | |
NFXL1 | Specific language impairment | SLI | SEQ, NGS | N | Syndro | |||
NIPA1 | 608145 | Spastic paraplegia type 6, autosomal dominant | SPG6 | 600363 | SEQ, MLPA, NGS | N | Neuro | |
NIPBL | 608667 | Cornelia de Lange syndrome 1 | CDLS1 | 122470 | SEQ, MLPA, NGS | N | Syndro | |
NKX2-1 | 600635 | Benign hereditary Chorea | BHC | 118700 | SEQ, MLPA, NGS | N | Neuro | |
NKX2-1 | 600635 | Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction | CAHTP, brain-lung-thyroid syndrome | 610978 | SEQ, MLPA, NGS | N | Neuro | |
NLRP3 | 606416 | Cryopyrin-associated periodic syndrome 3 | CAPS3, CINCA syndrome | 607115 | SEQ, NGS | N | Fever | |
NLRP3 | 606416 | Familial cold autoinflammatory syndrome | FCAS, cryopyrin-associated periodic syndrome 1, CAPS1 | 120100 | SEQ, NGS | N | Fever | |
NLRP3 | 606416 | Muckle-Wells syndrome | MWS, cryopyrin-associated periodic syndrome 2, CAPS2 | 191900 | SEQ, NGS | N | Fever | |
NOTCH3 | 600276 | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | CADASIL1 | 125310 | SEQ, MLPA, NGS | N | Neuro | |
NOTCH3 | 600276 | Myofibromatose, infantile, type 2 | IMF2 | 615293 | SEQ, MLPA, NGS | N | Neuro | |
NPC1 | 607623 | Niemann-Pick disease, type C1 | NPC1 | 257220 | SEQ, MLPA, NGS | N | Meta | |
NPC2 | 601015 | Niemann-Pick disease, type C2 | NPC2 | 607625 | SEQ, MLPA, NGS | N | Meta | |
NR5A1 | 184757 | 46XY sex reversal type 3 | SRXY3, gonadal dysgenesis | 612965 | SEQ, MLPA, NGS | N | Syndro | |
NR5A1 | 184757 | Premature ovarian failure 7 | POF7 | 612964 | SEQ, MLPA, NGS | N | Syndro | |
NR5A1 | 184757 | Spermatogenic failure type 8 | SPGF8 | 613957 | SEQ, MLPA, NGS | N | Syndro | |
NRAS | NRAS1 | 64790 | Noonan syndrome 6 | NS6 | 613224 | SEQ, NGS | N | Syndro |
NSD1 | 606681 | Sotos syndrome | cerebral gigantism | 117550 | SEQ, MLPA, NGS | N | Syndro | |
NTHL1 | 602656 | Familial adenomatous polyposis coli, familial polyposis of the colon, type 3 | FAP3 | 616415 | SEQ, NGS | N | Tumor | |
OCA2 | P gene, pink-eyed dilution | 611409 | Albinism, oculocutaneous, type 2 | OCA2 | 203200 | SEQ, MLPA, NGS | O | Meta |
OCRL | 300535 | Lowe syndrome | Oculocerebrorenal syndrome | 309000 | SEQ, NGS | O | Syndro | |
OFD1 | 300170 | Joubert syndrome type 10 | JBTS10 | 300804 | SEQ, NGS | O | Syndro | |
OFD1 | 300170 | Simpson-Golabi-Behmel syndrome, type 2 | SGBS2 | 300209 | SEQ, NGS | O | Syndro | |
OPA1 | 605290 | Deafness-optic atrophy plus syndrome | dominant optic atrophy plus syndrome, DOA+ | 125250 | SEQ, MLPA, NGS | O | Sensory | |
OPA1 | 605290 | Optic atrophy | Kjer type, OPA1 | 165500 | SEQ, MLPA, NGS | O | Sensory | |
OTC | 300461 | Ornithine transcarbamylase deficiency | Hyperammonemia due to OTC deficiency | 311250 | SEQ, MLPA, NGS | O | Meta | |
OTC | 300461 | Ornithine transcarbamylase deficiency | Hyperammonemia due to OTC deficiency | 311250 | SEQ, MLPA, NGS | O | Path | |
PABPN1 repeat | 602279 | Oculopharyngeal muscular dystrophy | OPMD | 164300 | REP | P | Neuro | |
PAFAH1B1 | LIS1 | 601545 | Lissencephaly type 1 | LIS1 | 607432 | SEQ, MLPA, NGS | P | Syndro |
PAFAH1B1 | LIS1 | 601545 | Subcortical laminar heterotopia | SCLH | 607432 | SEQ, MLPA, NGS | P | Syndro |
PAH | 612349 | Phenylketonuria | PKU, hyperphenylalaninemia | 261600 | SEQ, MLPA, NGS | P | Meta | |
PALB2 | FANCN | 610355 | Breast cancer, susceptibility | 114480 | SEQ, MLPA, NGS | P | Tumor | |
PALB2 | 610355 | Pancreatic cancer, susceptibility, type 3 | PNCA3 | 613348 | SEQ, MLPA, NGS | P | Tumor | |
PALLD | 608092 | Pancreatic cancer, susceptibility, type 1 | PNCA1 | 606856 | SEQ, NGS | P | Tumor | |
PANK2 | 606157 | HARP syndrome | Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration | 607236 | SEQ, MLPA, NGS | P | Syndro | |
PANK2 | 606157 | Neurodegeneration with brain iron accumulation, type 1 | NBIA1, formerly Hallervorden-Spatz disease | 234200 | SEQ, MLPA, NGS | P | Neuro | |
PARK2 | PRKN | 602544 | Parkinson disease, autosomal recessive, juvenile, type 2 | PARK2 | 600116 | SEQ, MLPA, NGS | P | Neuro |
PARK7 | DJ1 | 602533 | Parkinson disease, autosomal recessive, early-onset, type 7 | PARK7 | 606324 | SEQ, MLPA, NGS | P | Neuro |
PAX3 | 606597 | Waardenburg syndrome type 1 | WS1 | 193500 | SEQ, MLPA, NGS | P | Syndro | |
PAX3 | 606597 | Waardenburg syndrome, type 3 | WS3, Klein-Waardenburg-Syndrom | 148820 | SEQ, MLPA, NGS | P | Syndro | |
PAX5 | 167414 | Leukemia, acute lymphoblastic type 3, susceptibility | ALL3 | 615545 | SEQ, NGS | P | Tumor | |
PAX6 | 607108 | Aniridia | AN1, congenital cataract with late-onset corneal-dystrophy | 106210 | SEQ, MLPA, NGS | P | Sensory | |
PAX6 | 607108 | Anterior segment dysgenesis, type 5 | ASGD5 | 604229 | SEQ, MLPA, NGS | P | Sensory | |
PAX6 | 607108 | Foveal hypoplasia | FVH1 | 136520 | SEQ, MLPA, NGS | P | Sensory | |
PAX6 | 607108 | Optic nerve hypoplasia, bilateral | Optic nerve aplasia, bilateral | 165550 | SEQ, MLPA, NGS | P | Sensory | |
PAX9 | 167416 | Tooth agenesis, selective, 3 | STHAG3 | 604625 | SEQ, NGS | P | Syndro | |
PCDH19 | 300460 | Epilepsy, female-restricted with mental retardation | EFMR, Juberg-Hellman syndrome | 300088 | SEQ, MLPA, NGS | P | Epi | |
PCSK9 | 607786 | Hypercholesterolemia, familial, 3 | FHCL3 | 603776 | SEQ, NGS | P | Meta | |
PDE4D | 600129 | Acrodysostosis type 2, with or without hormone resistance | ACRDYS2 | 614613 | SEQ, NGS | P | Tissue | |
PDE6H | 601190 | Retinal cone dystrophy type 3A | RCD3A | 610024 | SEQ, NGS | P | Sensory | |
PDGFB | 190040 | Basal ganglia calcification, idiopathic, type 5, Fahr disease | IBGC5 | 615483 | SEQ, NGS | P | Neuro | |
PDGFRB | 173410 | Basal ganglia calcification, idiopathic, type 4, Fahr disease | IBGC4 | 615007 | SEQ, NGS | P | Neuro | |
PDGFRB | 173410 | Myofibromatose, infantile, type 1 | IMF1 | 228550 | SEQ, NGS | P | Neuro | |
PDX1 | IPF1 | 600733 | Maturity-onset diabetes of the young, type 4 | MODY4 | 606392 | SEQ, MLPA, NGS | P | Meta |
PDYN | 131340 | Spinocerebellar ataxia type 23 | SCA23 | 610245 | SEQ, NGS | P | Neuro | |
PGM3 | 172100 | Hyper-IgE syndrome, autosomal recessive | Immunodeficiency 23 | 615816 | SEQ, NGS | P | Meta | |
PHF6 | 300414 | Borjeson-Forssman-Lehmann syndrome | BFLS | 301900 | SEQ, MLPA, NGS | P | Syndro | |
PHOX2A | ARIX | 602753 | Congenital fibrosis of extraocular muscles type 2 | CFEOM2 | 602078 | SEQ, NGS | P | Sensory |
PIGV | 610274 | Hyperphosphatasia with mental retardation syndrome 1 | Mabry syndrome | 239300 | SEQ, NGS | P | Syndro | |
PIK3CA | 171834 | Cowden syndrome, type 5 | 615108 | SEQ, NGS | P | Tumor | ||
PINK1 | 608309 | Parkinson disease, autosomal recessive, early-onset, type 6 | PARK6 | 605909 | SEQ, MLPA, NGS | P | Neuro | |
PITX2 | 601542 | Anterior segment dysgenesis, type 4 | ASGD4 | 137600 | SEQ, MLPA, NGS | P | Sensory | |
PITX2 | 601542 | Axenfeld-Rieger syndrome type 1 | RIEG1 | 180500 | SEQ, MLPA, NGS | P | Sensory | |
PKD1 | 601313 | Polycystic kidney disease 1 | PKD1 | 173900 | SEQ, MLPA, NGS | P | Kidney | |
PKD1 | 601313 | Polycystic kidney disease type 1 | PKD1 | 173900 | SEQ, MLPA, NGS | P | Syndro | |
PKD2 | 173910 | Polycystic kidney disease 2 | PKD2 | 613095 | SEQ, MLPA, NGS | P | Kidney | |
PKD2 | 173910 | Polycystic kidney disease type 2 | PKD2 | 613095 | SEQ, MLPA, NGS | P | Syndro | |
PKLR | 609712 | Adenosine triphosphate, elevated, of erythrocytes | pyruvate kinase hyperactivity | 102900 | SEQ, MLPA, NGS | P | Meta | |
PKLR | 609712 | Pyruvate kinase deficiency of erythrocyte | 266200 | SEQ, MLPA, NGS | P | Meta | ||
PLA2G6 | 603604 | Neurodegeneration with brain iron accumulation, type 2A | NBIA2A, infantile neuroaxonal dystrophy | 256600 | SEQ, MLPA, NGS | P | Neuro | |
PLA2G6 | 603604 | Neurodegeneration with brain iron accumulation, type 2B | NBIA2B | 610217 | SEQ, MLPA, NGS | P | Neuro | |
PLA2G6 | 603604 | Parkinson disease, autosomal recessive, adult-onset, type 14 | PARK14, Dystonia-parkinsonismus | 612953 | SEQ, MLPA, NGS | P | Neuro | |
PLIN1 | 170290 | Lipodystrophy, familial partial, type 4 | FPLD4 | 613877 | SEQ, NGS | P | Meta | |
PMP22 | 601097 | Charcot-Marie-Tooth neuropathy type 1A | CMT1A, HMSN1A | 118220 | SEQ, MLPA, NGS | P | Neuro | |
PMP22 | 601097 | Charcot-Marie-Tooth neuropathy type 1E | CMT1E, HMSN1E | 118300 | SEQ, MLPA, NGS | P | Neuro | |
PMP22 | 601097 | Hereditay neuropathy with pressure palsies | HNPP, tomaculous neuropathy | 162500 | SEQ, MLPA, NGS | P | Neuro | |
PMS2 | 600259 | Hereditary nonpolyposis colorectal cancer type IV | HNPCC, Lynch syndrome | 614337 | SEQ, MLPA, NGS | P | Tumor | |
PNPLA6 | 603197 | Boucher-Neuhauser-syndrome | BNHS | 215470 | SEQ, NGS | P | Neuro | |
PNPLA6 | 603197 | Laurence-Moon syndrome | LNMS | 245800 | SEQ, NGS | P | Neuro | |
PNPLA6 | 603197 | Oliver-McFarlane syndrome | OMCS | 275400 | SEQ, NGS | P | Neuro | |
PNPLA6 | 603197 | Spastic paraplegia type 39, autosomal recessive | SPG39 | 612020 | SEQ, NGS | P | Neuro | |
POLD1 | 174761 | Colorectal Cancer, susceptibility type 10 | 612591 | SEQ, NGS | P | Tumor | ||
POLD1 | 174761 | Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome | MDPL | 615381 | SEQ, NGS | P | Syndro | |
POLE | 174762 | Colorectal Cancer, susceptibility type 12 | 615083 | SEQ, NGS | P | Tumor | ||
POLE | 174762 | Facial dysmorphism, immunodeficiency, livedo and short stature | FILS syndrome | 615139 | SEQ, NGS | P | Syndro | |
POLG | POLG1 | 174763 | Mitochondrial DNA depletion syndrome type 4A | MTDPS4A, Alpers syndrome | 203700 | SEQ, MLPA, NGS | P | Neuro |
POLG | POLG1 | 174763 | Mitochondrial DNA depletion syndrome type 4B | MTDPS4B, Mitochondrial neurogastrointestinal encephalopathy syndrome, MNGIE | 613662 | SEQ, MLPA, NGS | P | Neuro |
POLG | POLG1 | 174763 | Progressive external ophthalmoplegia autosomal recessive 1 | PEOB1, chronic progressive external ophthalmoplegia type 1, CPEO1 | 258450 | SEQ, MLPA, NGS | P | Neuro |
POLG | POLG1 | 174763 | Progressive external ophthalmoplegia autosomal dominant 1 | PEOA1, chronic progressive external ophthalmoplegia type 1, CPEO1 | 157640 | SEQ, MLPA, NGS | P | Neuro |
POLG | POLG1 | 174763 | Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | SANDO, sensory ataxic neuropathy with mitochondrial DNA deletions, autosomal recessive | 607459 | SEQ, MLPA, NGS | P | Neuro |
POLG | POLG1 | 174763 | Spinocerebellar ataxia with epilepsy | SCAE | 607459 | SEQ, MLPA, NGS | P | Neuro |
POLG2 | 604983 | Chronic progressive external ophthalmoplegia type 4 | CPEO4, PEOA4 progressive external ophthalmoplegia 4 | 610131 | SEQ, MLPA, NGS | P | Neuro | |
POLR1C | 610060 | Treacher-Collins-Franceschetti syndrome type 3, autosomal recessive | 248390 | SEQ, NGS | P | Syndro | ||
POLR1D | 613715 | Treacher-Collins-Franceschetti syndrome type 2 | 613717 | SEQ, NGS | P | Syndro | ||
POMC | 176830 | Obesity, early-onset, with adrenal insufficiency and red hair | OBAIRH | 609734 | SEQ, MLPA, NGS | P | Meta | |
PORCN | 300651 | Focal dermal hypoplasia | Goltz-Gorlin syndrome | 305600 | SEQ, NGS | P | Syndro | |
POU3F4 | 300039 | Deafness, X-linked type 2 | DFNX2 | 304400 | SEQ, MLPA, NGS | P | Sensory | |
POU3F4 | 300039 | Deafness, X-linked, conductive with stapes fixation | DFN3 | 304400 | SEQ, MLPA, NGS | P | Sensory | |
POU3F4 | 300039 | Gusher syndrome | 304400 | SEQ, MLPA, NGS | P | Sensory | ||
PPARG | 601487 | Diabetes mellitus, noninsulin-dependent | NIDDM | 125853 | SEQ, MLPA, NGS | P | Meta | |
PPARG | 601487 | Lipodystrophy, familial partial, type 3 | FPLD3 | 604367 | SEQ, MLPA, NGS | P | Meta | |
PPP2R2B repeat | 604325 | Spinocerebellar ataxia type 12 | SCA12 | 604326 | REP | P | Neuro | |
PPT1 | 600722 | Ceroid-Lipofuscinose, neuronal, Typ 1 | CLN1, infantile Santavuori-Haltia disease included | 256730 | SEQ, MLPA, NGS | P | Meta | |
PRKAR1A | 188830 | Acrodysostosis type 1, with or without hormone resistance | ACRDYS1 | 101800 | SEQ, MLPA, NGS | P | Tissue | |
PRKAR1A | 188830 | Carney complex, type 1 | CNC1 | 160980 | SEQ, MLPA, NGS | P | Tumor | |
PRKAR1A | 188830 | Intracardiac myxoma | 255960 | SEQ, MLPA, NGS | P | Tumor | ||
PRKAR1A | 188830 | Pigmented nodular adrenocortical disease, primary, 1 | PPNAD1 | 610489 | SEQ, MLPA, NGS | P | Tumor | |
PRKAR1A | 188830 | Pigmented nodular adrenocortical disease, primary, 1 | PPNAD1 | 610489 | SEQ, MLPA, NGS | P | Kidney | |
PRKCSH | 177060 | Polycystic liver disease 1 | PCLD1 | 174050 | SEQ, NGS | P | Syndro | |
PRKG1 | 176894 | Thoracic aortic aneurysm type 8 | AAT8 | 615436 | SEQ, NGS | P | Tissue | |
PRNP | 176640 | Creutzfeld-Jakob disease | familial, CJD | 123400 | SEQ, NGS | P | Neuro | |
PRNP | 176640 | Fatal familial insomnia | FFI | 600072 | SEQ, NGS | P | Neuro | |
PRNP | 176640 | Gerstmann-Sträussler-Scheinker syndrome | GSSS | 137440 | SEQ, NGS | P | Neuro | |
PRNP | 176640 | Huntington disease-like 1 | HDL1 | 603218 | SEQ, NGS | P | Neuro | |
PRNP | 176640 | Prion disease with protracted course | 606688 | SEQ, NGS | P | Neuro | ||
PROC | 612283 | Protein C deficiency, autosomal dominant | THPH3 | 176860 | SEQ, MLPA, NGS | P | Coagul | |
PROC | 612283 | Protein C deficiency, autosomal recessive | THPH4 | 612304 | SEQ, MLPA, NGS | P | Coagul | |
PRODH | 606810 | Hyperprolinemia, type I | HYRPRO1 | 239500 | SEQ, NGS | P | Meta | |
PROS1 | 176880 | Protein S deficiency, autosomal dominant | THPH5 | 612336 | SEQ, MLPA, NGS | P | Coagul | |
PROS1 | 176880 | Protein S deficiency, autosomal recessive | THPH6 | 614514 | SEQ, MLPA, NGS | P | Coagul | |
PRPH2 | 179605 | Choroidal dystrophy, central areolar, type 2 | CACD | 613105 | SEQ, MLPA, NGS | P | Sensory | |
PRPH2 | 179605 | Leber congenital amaurosis type 18 | LCA18 | 608133 | SEQ, MLPA, NGS | P | Sensory | |
PRPH2 | 179605 | Patterned dystrophy of retinal pigment epithelium, butterfly shaped | MDPT1 | 169150 | SEQ, MLPA, NGS | P | Sensory | |
PRPH2 | 179605 | Retinitis pigmentosa type 7, digenic included | RP7 | 608133 | SEQ, MLPA, NGS | P | Sensory | |
PRPH2 | 179605 | Retinitis punctata albescens | RPA | 136880 | SEQ, MLPA, NGS | P | Sensory | |
PRPH2 | 179605 | Vitelliform macular dystrophy, type 3 | VMD3 | 608161 | SEQ, MLPA, NGS | P | Sensory | |
PRPS1 | 311850 | Arts syndrome | ARTS | 301835 | SEQ, NGS | P | Syndro | |
PRPS1 | 311850 | Charcot-Marie-Tooth neuropathy type X5 | Rosenberg-Chutorian-syndrome, CMTX5 | 311070 | SEQ, NGS | P | Neuro | |
PRPS1 | 311850 | Deafness, X-linked, type 1 | DFNX1 | 304500 | SEQ, NGS | P | Sensory | |
PRPS1 | 311850 | Phosphoribosylpyrophosphate synthetase superactivity | PRPS-related Gout, hyperuricemia | 300661 | SEQ, NGS | P | Meta | |
PRRT2 | 614386 | Benign familial infantile seizures, type 2 | BFIE2 | 605751 | SEQ, MLPA, NGS | P | Epi | |
PRRT2 | 614386 | Infantile, familial convulsions with paroxysmal choreoathetosis | ICCA | 602066 | SEQ, MLPA, NGS | P | Neuro | |
PRRT2 | 614386 | Paroxysmal kinesigenic dyskinesia | PKD, Dystonie 10 | 128200 | SEQ, MLPA, NGS | P | Neuro | |
PRSS1 | 276000 | Hereditary pancreatitis | PCTT | 167800 | SEQ, MLPA, NGS | P | Tumor | |
PSAP | 176801 | Atypical Gaucher disease due to saposin C deficiency | 610539 | SEQ, NGS | P | Meta | ||
PSAP | 176801 | Atypical Krabbe disease due to saposin A deficiency | Saposin A deficiency | 611722 | SEQ, NGS | P | Meta | |
PSAP | 176801 | Combined saposin deficiency | 611721 | SEQ, NGS | P | Neuro | ||
PSAP | 176801 | Metachromatic leukodystrophy due to saposin B deficiency | Saposin B deficiency | 249900 | SEQ, NGS | P | Meta | |
PSEN1 | 104311 | Alzheimer disease type 3, familial | DAT | 607822 | SEQ, MLPA, NGS | P | Neuro | |
PSEN1 | 104311 | Cardiomyopathy, dilated,1U | CMD1U | 613694 | SEQ, MLPA, NGS | P | Cardio | |
PSEN1 | 104311 | Pick disease of brain | Dementia with lobar atrophy and neuronal cytoplasmic inclusions | 172700 | SEQ, MLPA, NGS | P | Neuro | |
PSEN2 | 600759 | Alzheimer disease type 4, familial | DAT | 606889 | SEQ, MLPA, NGS | P | Neuro | |
PSEN2 | 600759 | Cardiomyopathy, dilated,1V | CMD1V | 613697 | SEQ, MLPA, NGS | P | Cardio | |
PSTPIP1 | 606347 | Pyogenic sterile arthritis, pyoderma gangrenosum, and acne | PAPA syndrome | 604416 | SEQ, NGS | P | Tissue | |
PTCH1 | 601309 | Basal cell nevus syndrome | BCNS, Gorlin-Goltz syndrome | 109400 | SEQ, MLPA, NGS | P | Tumor | |
PTCH2 | 603673 | Basal cell nevus syndrome | BCNS, Gorlin-Goltz syndrome | 109400 | SEQ, NGS | P | Tumor | |
PTEN | 601728 | Bannayan-Riley-Ruvalcaba syndrome | BBRS | 158350 | SEQ, MLPA, NGS | P | Tumor | |
PTEN | 601728 | Cowden syndrome, type 1 | 158350 | SEQ, MLPA, NGS | P | Tumor | ||
PTEN | 601728 | Lhermitte-Duclos syndrome | 158350 | SEQ, MLPA, NGS | P | Tumor | ||
PTEN | 601728 | PTEN hamartoma tumor syndrome | 158350 | SEQ, MLPA, NGS | P | Tumor | ||
PTH1R | 168468 | Chondrodysplasia, Blomstrand type | 215045 | SEQ, NGS | P | Tissue | ||
PTH1R | 168468 | Eiken skeletal dysplasia | Eiken syndrome | 600002 | SEQ, NGS | P | Tissue | |
PTH1R | 168468 | Failure of tooth eruption, primary, nonsyndromic | 125350 | SEQ, NGS | P | Tissue | ||
PTH1R | 168468 | Metaphyseal chondrodysplasia, Murk Jansen type | 156400 | SEQ, NGS | P | Tissue | ||
PTHLH | 168470 | Brachydactyly, type E2 | BDE2 | 613382 | SEQ, NGS | P | Tissue | |
PTPN11 | 176876 | LEOPARD syndrome 1 | 151100 | SEQ, NGS | P | Syndro | ||
PTPN11 | 176876 | Metachondromatosis | 156250 | SEQ, NGS | P | Tissue | ||
PTPN11 | 176876 | Noonan syndrome 1 | NS1 | 163950 | SEQ, NGS | P | Syndro | |
PYGM | 608455 | Glycogen storage disease V | GSD5, McArdle disease | 232600 | SEQ, NGS | P | Meta | |
RAB7A | 602298 | Charcot-Marie-Tooth neuropathy type 2B | CMT2B, HMSN2B | 600882 | SEQ, MLPA, NGS | R | Neuro | |
RAD51C | FANCO | 602774 | Familial breast-ovarian cancer type 3 | HBOC3 | 613399 | SEQ, MLPA, NGS | R | Tumor |
RAD51D | 602954 | Familial breast-ovarian cancer type 4 | HBOC4 | 614291 | SEQ, MLPA, NGS | R | Tumor | |
RAF1 | 164760 | LEOPARD syndrome 2 | 611554 | SEQ, NGS | R | Syndro | ||
RAF1 | 164760 | Noonan syndrome 5 | NS5 | 611553 | SEQ, NGS | R | Syndro | |
RAI1 (sequencing) | 607642 | Smith-Magenis syndrome | 182290 | SEQ, MLPA, NGS | R | Syndro | ||
RB1 | 614041 | Retinoblastoma | RB | 180200 | SEQ, MLPA, NGS | R | Tumor | |
REEP1 | 609139 | Hereditary motor neuropathy type VB, distal | HMN5B | 614751 | SEQ, MLPA, NGS | R | Neuro | |
REEP1 | 609139 | Spastic paraplegia type 31, autosomal dominant | SPG31 | 610250 | SEQ, MLPA, NGS | R | Neuro | |
RET | 164761 | Familial medullary thyroid carcinoma | FMTC | 155240 | SEQ, MLPA, NGS | R | Tumor | |
RET | 164761 | Hirschsprung disease type 1 | HSCR1 | 142623 | SEQ, MLPA, NGS | R | Syndro | |
RET | 164761 | Multiple endocrine neoplasia type 2 A | MEN2A | 171400 | SEQ, MLPA, NGS | R | Tumor | |
RET | 164761 | Multiple endocrine neoplasia type 2 B | MEN2B | 162300 | SEQ, MLPA, NGS | R | Tumor | |
RET | 164761 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | R | Kidney | |
RET | 164761 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | R | Tumor | |
RIT1 | 609591 | Noonan syndrome 8 | NS8 | 615355 | SEQ, NGS | R | Syndro | |
RNF135 | Makrozephalie-Makrosomie-Faziale Dysmorphie-Syndrom | Chromosome 17q11.2 deletion syndrome | 613675 | SEQ, NGS | R | Syndro | ||
RNF43 | 612482 | Sessile serrated polyposis cancer syndrome | SSPCS | 617108 | SEQ, NGS | R | Neuro | |
RPS6KA3 | 300075 | Coffin-Lowry syndrome | 303600 | SEQ, MLPA, NGS | R | Syndro | ||
RPS6KA3 | 300075 | Mental retardation, X-linked 19 | MRX19 | 300844 | SEQ, MLPA, NGS | R | Syndro | |
RRM2B | 604712 | Chronic progressive external ophthalmoplegia type 5 | CPEO5, PEOA5 progressive external ophthalmoplegia 5 | 613077 | SEQ, MLPA, NGS | R | Neuro | |
RRM2B | 604712 | Mitochondrial DNA depletion syndrome type 8A | MTDPS8A | 612075 | SEQ, MLPA, NGS | R | Neuro | |
RRM2B | 604712 | Mitochondrial DNA depletion syndrome type 8B | MNGIE , mitochondrial neurogastrointestinal encephalopathy syndrome, MTDPS8B | 612075 | SEQ, MLPA, NGS | R | Neuro | |
RS1 | 300839 | Retinoschisis 1, X-linked, juvenile | 312700 | SEQ, NGS | R | Sensory | ||
RUNX2 | 600211 | Cleidocranial dysplasia | CCD | 119600 | SEQ, MLPA, NGS | R | Tissue | |
RUNX2 | 600211 | Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly | MDMHB | 156510 | SEQ, MLPA, NGS | R | Tissue | |
SACS | 604490 | Spastic Ataxia, Charlevoix-Saguenay type | SACS, spastic ataxia, autosomal recessive type 6, SPAX6, ARSACS | 270550 | SEQ, MLPA, NGS | S | Neuro | |
SALL1 | 602218 | Townes-Brocks syndrome | TBS | 107480 | SEQ, MLPA, NGS | S | Syndro | |
SALL4 | 607343 | Duane-radial ray syndrome | Okihiro syndrome | 607323 | SEQ, MLPA, NGS | S | Syndro | |
SALL4 | 607343 | IVIC syndrome | 147750 | SEQ, MLPA, NGS | S | Syndro | ||
SAMHD1 | 606754 | Aicardi-Goutieres syndrome type 5 | AGS5 | 612952 | SEQ, MLPA, NGS | S | Syndro | |
SAMHD1 | 606754 | Chilblain lupus type 2 | CHBL2 | 614415 | SEQ, MLPA, NGS | S | Geno | |
SATB2 | 608148 | 2q32-q33-Microdeletion syndrome | Glass syndrome | 612313 | MLPA | S | Micro | |
SATB2 | 608148 | Glass syndrome | SATB2-associated syndrome | 612313 | SEQ, MLPA, NGS | S | Syndro | |
SCN1A | 182389 | Dravet syndrome | Severe myoclonic epilepsy of infancy, SMEI | 607208 | SEQ, MLPA, NGS | S | Epi | |
SCN1A | 182389 | Familial hemiplegic migraine type 3 | FHM3 | 609634 | SEQ, MLPA, NGS | S | Neuro | |
SCN1A | 182389 | Generalized epilepsy with febrile seizures plus, type 2 | GEFS+2 | 604403 | SEQ, MLPA, NGS | S | Epi | |
SCN1A | 182389 | Intractable childhood epilepsy with generalized tonic-clonic seizures | ICEGTC | 607208 | SEQ, MLPA, NGS | S | Epi | |
SCN1B | 600235 | Brugada syndrome type 5 | BRGDA5 | 612838 | SEQ, NGS | S | Cardio | |
SCN1B | 600235 | Generalized epilepsy with febrile seizures plus, type 1 | GEFS+1 | 604233 | SEQ, NGS | S | Epi | |
SCN3B | 608214 | Brugada syndrome type 7 | BRGDA7 | 613120 | SEQ, NGS | S | Cardio | |
SCN4A | 603967 | Hyperkalemic periodic paralysis type 2 | HYPP | 170500 | SEQ, MLPA, NGS | S | Neuro | |
SCN4A | 603967 | Hypokalemic periodic paralysis type 2 | HOKPP2 | 613345 | SEQ, MLPA, NGS | S | Neuro | |
SCN4A | 603967 | Myotonia congenita, acetazolamide-responsive | sodium channel myotonia | 608390 | SEQ, MLPA, NGS | S | Neuro | |
SCN4A | 603967 | Paramyotonia congenita of von Eulenburg | PMC | 168300 | SEQ, MLPA, NGS | S | Neuro | |
SCN5A | 600163 | Brugada syndrome type 1 | BRGDA1, Right bundle branch block, ST segment elevation, sudden death | 601144 | SEQ, MLPA, NGS | S | Cardio | |
SCN5A | 600163 | Cardiomyopathy, dilated, 1E | CMD1E | 601154 | SEQ, MLPA, NGS | S | Cardio | |
SCN5A | 600163 | Long QT syndrome 3 | LQT3, Romano-Ward syndrome 3 | 603830 | SEQ, MLPA, NGS | S | Cardio | |
SCN5A | 600163 | Sick sinus syndrome 1 | SSS1, autosomal recessive | 608567 | SEQ, MLPA, NGS | S | Cardio | |
SCN9A | 603415 | Erythromelalgia, primary | erythermalgia | 133020 | SEQ, NGS | S | Neuro | |
SCN9A | 603415 | Generalized epilepsy with febrile seizures plus, type 7 | GEFS+7 | 613863 | SEQ, NGS | S | Epi | |
SCN9A | 603415 | Insensitivity to pain, congenital, autosomal recessive | congenital indifference to pain, autosomal recessive, CIP | 243000 | SEQ, NGS | S | Neuro | |
SCN9A | 603415 | Paroxysmal extreme pain disorder | PEXPD or PEPD | 167400 | SEQ, NGS | S | Neuro | |
SDHA | 600857 | Cardiomyopathy, dilated,1GG | CMD1GG | 613642 | SEQ, MLPA, NGS | S | Cardio | |
SDHA | 600857 | Leigh syndrome | 256000 | SEQ, MLPA, NGS | S | Neuro | ||
SDHA | 600857 | Mitochondrial complex II deficiency | 252011 | SEQ, MLPA, NGS | S | Neuro | ||
SDHA | 600857 | Paragangliomas, familial, type 5 | PGL5 | 614165 | SEQ, MLPA, NGS | S | Tumor | |
SDHAF2 | SDH5 | 613019 | Paragangliomas, familial, type 2 | PGL2 | 601650 | SEQ, MLPA, NGS | S | Tumor |
SDHAF2 | SDH5 | 613019 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, MLPA, NGS | S | Tumor | |
SDHAF2 | SDH5 | 613019 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, MLPA, NGS | S | Tumor | |
SDHB | 185470 | Cowden syndrome, type 2 | 612359 | SEQ, MLPA, NGS | S | Tumor | ||
SDHB | 185470 | Paragangliomas, familial, type 4 | PGL4 | 115310 | SEQ, MLPA, NGS | S | Tumor | |
SDHB | 185470 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | S | Kidney | |
SDHB | 185470 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | S | Tumor | |
SDHB | 185470 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, MLPA, NGS | S | Kidney | ||
SDHB | 185470 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, MLPA, NGS | S | Kidney | ||
SDHC | 602413 | Paragangliomas, familial, type 3 | PGL3 | 605373 | SEQ, MLPA, NGS | S | Tumor | |
SDHC | 602413 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | S | Kidney | |
SDHC | 602413 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | S | Tumor | |
SDHC | 602413 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, MLPA, NGS | S | Tumor | ||
SDHC | 602413 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, MLPA, NGS | S | Tumor | ||
SDHD | 602690 | Cowden syndrome, type 3 | 615106 | SEQ, MLPA, NGS | S | Tumor | ||
SDHD | 602690 | Paragangliomas, familial, type 1 | PGL1 | 168000 | SEQ, MLPA, NGS | S | Tumor | |
SDHD | 602690 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | S | Kidney | |
SDHD | 602690 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | S | Tumor | |
SDHD | 602690 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, MLPA, NGS | S | Kidney | ||
SDHD | 602690 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, MLPA, NGS | S | Kidney | ||
SEC63 | 608648 | Polycystic liver disease 2 | PCLD2 | 174050 | SEQ, NGS | S | Syndro | |
Sept.9 | 604061 | Hereditary neuralgic amyotrophy | HNA | 162100 | SEQ, NGS | S | Neuro | |
SERPINA1, exons 3 and 5 | 107400 | Alpha-1-antitrypsin deficiency | A1ATD | 613490 | SEQ, MLPA | S | Meta | |
SERPINC1 | 107300 | Thrombophilia due to antithrombin III deficiency | AT3D | 613118 | SEQ, MLPA, NGS | S | Coagul | |
SERPING1 | C1NH | 606860 | Angioedema, hereditary, types I and II | HAE1, HAE2 | 106100 | SEQ, MLPA, NGS | S | Meta |
SERPING1 | 606860 | Partial deficiency of complement component 4 | 120790 | SEQ, MLPA, NGS | S | Coagul | ||
SETX | 608465 | Amyotrophic lateral sclerosis type 4, juvenile | ALS4 | 602433 | SEQ, MLPA, NGS | S | Neuro | |
SETX | 608465 | Spinocerebellar ataxia, autosomal recessive type 1 | AOA2 | 606002 | SEQ, MLPA, NGS | S | Neuro | |
SGCE | 604149 | Dystonia-11, myoclonic | DYT11 | 159900 | SEQ, MLPA, NGS | S | Neuro | |
SH3BP2 | 602104 | Cherubism | CRBM | 118400 | SEQ, NGS | S | Syndro | |
SH3PXD2B | 613293 | Frank-ter Haar syndrome | FTHS | 249420 | SEQ, NGS | S | Syndro | |
SHOC2 | 602775 | Noonan syndrome-like with loose anagen hair | 607721 | SEQ, NGS | S | Syndro | ||
SHOX | 312865 | Dyschondrosteosis Leri-Weill type | LWD | 127300 | SEQ, MLPA, NGS | S | Tissue | |
SIL1 | 608005 | Marinesco-Sjorgren syndrome | MSS | 248800 | SEQ, NGS | S | Neuro | |
SIM1 | 603128 | Obesity | SEQ, MLPA, NGS | S | Meta | |||
SKI | 164780 | Shprintzen-Goldberg syndrome | Shprintzen-Goldberg craniosynostosis syndrome | 182212 | SEQ, NGS | S | Syndro | |
SKI | 164780 | Shprintzen-Goldberg syndrome | Shprintzen-Goldberg Craniosynostosis syndrome | 182212 | SEQ, NGS | S | Tissue | |
SLC1A3 | 600111 | Episodic ataxia type 6 | EA6 | 612656 | SEQ, NGS | S | Neuro | |
SLC20A2 | 158378 | Basal ganglia calcification, idiopathic, type 1, Fahr disease | IBGC1 | 213600 | SEQ, NGS | S | Neuro | |
SLC24A5 | 609802 | Albinism, oculocutaneous, type 6 | OCA6 | 113750 | SEQ, NGS | S | Meta | |
SLC25A13 | 603859 | Citrullinemia, type II, adult-onset | CTLN2, Citrin deficiency | 603471 | SEQ, NGS | S | Meta | |
SLC25A13 | 603859 | Citrullinemia, type II, adult-onset | CTLN2, citrin deficiency | 603471 | SEQ, NGS | S | Path | |
SLC25A13 | 603859 | Citrullinemia, type II, neonatal-onset | Cholestasis, neonatal intrahepatic, caused by citrin deficiency, NICCD | 605814 | SEQ, NGS | S | Meta | |
SLC25A13 | 603859 | Citrullinemia, type II, neonatal-onset | Neonatal intrahepatic cholestasis caused by citrin deficiency, NICCD | 605814 | SEQ, NGS | S | Path | |
SLC25A15 | 603861 | Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome | HHH syndrome | 238970 | SEQ, NGS | S | Meta | |
SLC25A15 | 603861 | Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome | HHH syndrome | 238970 | SEQ, NGS | S | Path | |
SLC25A38 | 610819 | Sideroblastic Anemia 2, pyridoxine-refractory | 205950 | SEQ, NGS | S | Coagul | ||
SLC25A4 | ANT1 | 103220 | Chronic progressive external ophthalmoplegia type 2 | CPEO2, PEOA2 progressive external ophthalmoplegia 2 | 609283 | SEQ, MLPA, NGS | S | Neuro |
SLC25A4 | 103220 | Mitochondrial DNA depletion syndrome type 12, cardiomyopathic type | MTDPS12 | 615418 | SEQ, MLPA, NGS | S | Neuro | |
SLC2A1 | GLUT1 | 138140 | Glucose transport defect, blood-brain barrier | GLUT1-deficiency syndrome 1 | 606777 | SEQ, MLPA, NGS | S | Neuro |
SLC2A1 | GLUT1 | 138140 | GLUT1 deficiency syndrome 1 | GLUT1DS1 | 606777 | SEQ, MLPA, NGS | S | Epi |
SLC45A2 | MATP | 606202 | Albinism, oculocutaneous, type 4 | OCA4 | 606574 | SEQ, NGS | S | Meta |
SLC6A19 | 608893 | Hartnup disorder | HND | 234500 | SEQ, NGS | S | Meta | |
SLCO1B1*5 Genetic Variant | c.521T>C, p.V174A | 604843 | Association with statin-induced side effects | SEQ | S | Pharma | ||
SMAD3 | 603109 | Loeys-Dietz syndrome type 3 | LDS3, aneurysms-osteoarthritis syndrome | 613795 | SEQ, NGS | S | Tissue | |
SMAD4 | MADH4 | 600993 | Juvenile polyposis with hereditary hemorrhagic teleangiectasia syndrome | JP/HHT | 175050 | SEQ, MLPA, NGS | S | Tumor |
SMAD4 | MADH4 | 600993 | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | JP/HHT | 175050 | SEQ, MLPA, NGS | S | Tissue |
SMAD4 | MADH4 | 600993 | Juvenile, intestinal polyposis | JIP | 174900 | SEQ, MLPA, NGS | S | Tumor |
SMN1 | 600354 | Spinal muscular atrophy type I | SMA1, Werdnig-Hoffmann disease | 253300 | SEQ, MLPA, NGS | S | Neuro | |
SMN1 | 600354 | Spinal muscular atrophy type II | SMA2 | 253550 | SEQ, MLPA, NGS | S | Neuro | |
SMN1 | 600354 | Spinal muscular atrophy type III | SMA3 | 253400 | SEQ, MLPA, NGS | S | Neuro | |
SMN1 | 600354 | Spinal muscular atrophy type IV, adult form | SMA4 | 271150 | SEQ, MLPA, NGS | S | Neuro | |
SMN2 | 601627 | Spinal muscular atrophy, type III, modifier of | SMA | 253400 | SEQ, MLPA, NGS | S | Neuro | |
SMPD1 | 607608 | Niemann-Pick disease, type A | 257200 | SEQ, MLPA, NGS | S | Meta | ||
SMPD1 | 607608 | Niemann-Pick disease, type B | 607616 | SEQ, MLPA, NGS | S | Meta | ||
SNAI2 | 602150 | Waardenburg syndrome, type 2D | WS2D | 608890 | SEQ, MLPA, NGS | S | Syndro | |
SNCA | 163890 | Lewy-Body dementia | Lewy-Body variant of Alzheimer disease | 127750 | SEQ, MLPA, NGS | S | Neuro | |
SNCA | 163890 | Parkinson disease, autosomal dominant, type 1 | PARK1, Lewy Body Parkinson disease | 168601 | SEQ, MLPA, NGS | S | Neuro | |
SNCA | 163890 | Parkinson disease, autosomal dominant, type 4 | PARK4, Lewy Body Parkinson disease | 605543 | SEQ, MLPA, NGS | S | Neuro | |
SNCA rs11931074 | 163890 | Multiple system atrophy | MSA | 146500 | SEQ | S | Neuro | |
SNCB | 602569 | Lewy-Body dementia | Lewy-Body variant of Alzheimer disease | 127750 | SEQ, NGS | S | Neuro | |
SOD1 | 147450 | Amyotrophic lateral sclerosis type 1 | ALS1 | 105400 | SEQ, NGS | S | Neuro | |
SORD | 182500 | Sorbitol dehydrogenase deficiency with peripheral neuropathy | SORDD | 618912 | SEQ, NGS | S | Neuro | |
SOS1 | 182530 | Noonan syndrome 4 | NS4 | 610733 | SEQ, NGS | S | Syndro | |
SOX10 | 602229 | Waardenburg syndrome type 2E | WS2E | 611584 | SEQ, MLPA, NGS | S | Syndro | |
SOX10 | 602229 | Waardenburg syndrome, type 4C | WS4C | 613266 | SEQ, MLPA, NGS | S | Syndro | |
SOX10 | 602229 | Waardenburg-Shah syndrome, PCWH syndrome | 609136 | SEQ, MLPA, NGS | S | Syndro | ||
SOX2 | 184429 | Anophthalmia / Microphthalmia, syndromic | SOX2-related eye disorders | 206900 | SEQ, MLPA, NGS | S | Syndro | |
SOX2 | 184429 | Microphthalmia, syndromic | MCOPS3, optic nerve hypoplasia and abnormalities of the central nervous system | 206900 | SEQ, MLPA, NGS | S | Syndro | |
SOX9 | 608160 | Campomelic dysplasia | CMPD | 114290 | SEQ, MLPA, NGS | S | Syndro | |
SOX9 | 608160 | Campomelic dysplasia with autosomal sex reversal | CMPD | 114290 | SEQ, MLPA, NGS | S | Syndro | |
SPAST | SPG4 | 604277 | Spastic paraplegia type 4, autosomal dominant | SPG4 | 182601 | SEQ, MLPA, NGS | S | Neuro |
SPG11 | KIAA1840, Spatacsin | 610844 | Spastic paraplegia type 11, autosomal recessive | SPG11, spastic paraplegia with thin corpus callosum | 604360 | SEQ, MLPA, NGS | S | Neuro |
SPG20 | KIAA0610, Spartin | 607111 | Spastic paraplegia type 20, autosomal recessive | SPG20, spastic paraplegia with distal muscle wasting, Troyer syndrome | 275900 | SEQ, NGS | S | Neuro |
SPG7 | 602783 | Spastic paraplegia type 7, autosomal recessive | SPG7 | 607259 | SEQ, MLPA, NGS | S | Neuro | |
SPINK1 | 167790 | Hereditary pancreatitis | PCTT | 167800 | SEQ, MLPA, NGS | S | Tumor | |
SPR | 182125 | DOPA-responsive dystonia due to sepiapterin reductase deficiency | 612716 | SEQ, NGS | S | Neuro | ||
SPRED1 | 609291 | Legius syndrome | Neurofibromatosis type 1-like syndrome | 611431 | SEQ, MLPA, NGS | S | Syndro | |
SPRED1 | 609291 | Neurofibromatosis type 1-like syndrome | Legius syndrome | 611431 | SEQ, MLPA, NGS | S | Tumor | |
SPTLC1 | 605712 | Hereditary, sensory and autonomic neuropathy type IA | HSAN1A, HSN1A | 162400 | SEQ, MLPA, NGS | S | Neuro | |
SQSTM1 | 601530 | Paget disease of bone | PDB3 | 602080 | SEQ, NGS | S | Tissue | |
SRCAP exon 30 to 34 | 611421 | Floating-Harbor syndrome | FHS | 136140 | SEQ | S | Syndro | |
SRY | 480000 | 46XY sex reversal type 1 | SRXY1, gonadal dysgenesis, true hermaphroditism | 400044 | SEQ, MLPA, NGS | S | Syndro | |
STAT3 | 102582 | Hyper-IgE recurrent infection syndrome, autosomal dominant | HIES, Job syndrome | 147060 | SEQ, MLPA, NGS | S | Meta | |
STK11 | 602216 | Peutz-Jeghers syndrome | PJS | 175200 | SEQ, MLPA, NGS | S | Tumor | |
SUCLA2 | 603921 | Mitochondrial DNA depletion syndrome type 5 | MTDPS5 | 612073 | SEQ, MLPA, NGS | S | Neuro | |
SUCLG1 | 611224 | Mitochondrial DNA depletion syndrome type 9 | MTDPS9 | 245400 | SEQ, MLPA, NGS | S | Neuro | |
SUFU | 607035 | Basal cell nevus syndrome | BCNS, Gorlin-Goltz syndrome | 109400 | SEQ, MLPA, NGS | S | Tumor | |
SUFU | 607035 | Medulloblastoma, desmoplastic | 155255 | SEQ, MLPA, NGS | S | Tumor | ||
TARDBP | TDP43 | 605078 | Amyotrophic lateral sclerosis type 10 | ALS10 | 612069 | SEQ, NGS | T | Neuro |
TARDBP | TDP43 | 605078 | Frontotemporal dementia with TDP43 inclusions | 612069 | SEQ, NGS | T | Neuro | |
TBP | 600075 | Spinocerebellar ataxia type 17 | SCA17 | 607136 | REP | T | Neuro | |
TBP repeat | 600075 | Huntington disease-like 4 | HDL4 | 607136 | REP | T | Neuro | |
TBX5 | 601620 | Holt-Oram syndrome | HOS | 142900 | SEQ, MLPA, NGS | T | Syndro | |
TCN2 | 613441 | Transcobalamin II deficiency | 275350 | SEQ, NGS | T | Meta | ||
TCOF1 | 606847 | Treacher-Collins-Franceschetti syndrome | 154500 | SEQ, MLPA, NGS | T | Syndro | ||
TECRL | 617242 | Catecholaminergic polymorphic ventricular tachycardia-3 | CPVT3 | 614021 | SEQ, NGS | T | Cardio | |
TECTA | 602574 | Deafness, autosomal dominant type 8/12 | DFNA12/DFNA8 | 601543 | SEQ, NGS | T | Sensory | |
TECTA | 602574 | Deafness, autosomal recessive type 21 | DFNB21 | 603629 | SEQ, NGS | T | Sensory | |
TGFB1 | 190180 | Camurati-Engelmann disease | 131300 | SEQ, NGS | T | Tissue | ||
TGFB2 | 190220 | Loeys-Dietz syndrome type 4 | LDS4 | 614816 | SEQ, NGS | T | Tissue | |
TGFB3 | 190230 | Loeys-Dietz syndrome type 5 | LDS5 | 615582 | SEQ, MLPA, NGS | T | Tissue | |
TGFBR1 | 190181 | Loeys-Dietz syndrome type 1 | LDS1, Furlong syndrome | 609192 | SEQ, MLPA, NGS | T | Tissue | |
TGFBR1 | 190181 | Thoracic aortic aneurysm type 5 | AAT5 | 609192 | SEQ, MLPA, NGS | T | Tissue | |
TGFBR2 | 190182 | Loeys-Dietz syndrome type 2 | LDS2 | 610168 | SEQ, MLPA, NGS | T | Tissue | |
TGFBR2 | 190182 | Thoracic aortic aneurysm type 3 | AAT3, FAA3 | 610168 | SEQ, MLPA, NGS | T | Tissue | |
TH | DYT5B | 191290 | DOPA-responsive dystonia, autosomal recessive | DRD, Segawa syndrome | 605407 | SEQ, MLPA, NGS | T | Neuro |
THAP1 | 609520 | Torsion dystonia type 6 | DYT6 | 602629 | SEQ, MLPA, NGS | T | Neuro | |
THRB | 190160 | Thyroid hormone resistance, generalized, autosomal dominant | GRTH | 188570 | SEQ, NGS | T | Meta | |
THRB | 190160 | Thyroid hormone resistance, generalized, autosomal recessive | GRTH, Refetoff syndrome | 274300 | SEQ, NGS | T | Meta | |
THRB | 190160 | Thyroid hormone resistance, selective pituitary | PRTH | 145650 | SEQ, NGS | T | Meta | |
TMEM126A | 612988 | Optic atrophy-7 with or without auditory neuropathy | OPA7 | SEQ, NGS | T | Sensory | ||
TMEM127 | 613403 | Pheochromocytoma | PCC | 171300 | SEQ, NGS | T | Kidney | |
TMEM127 | 613403 | Pheochromocytoma | PCC | 171300 | SEQ, NGS | T | Tumor | |
TMEM127 | 613403 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, NGS | T | Kidney | ||
TMEM127 | 613403 | Pheochromocytoma / Paraganglioma syndromes, familial | PCC/PGL | SEQ, NGS | T | Tumor | ||
TMPRSS6 | 609862 | Iron-refractory iron deficiency anemia | IRIDA | 206200 | SEQ, NGS | T | Meta | |
TNFRSF13B | TACI | 604907 | Immunodeficiency, common variable, type 2 | CVID2, antibody deficiency, hypogammaglobulinemia due to taci defect | 240500 | SEQ, NGS | T | Meta |
TNFRSF13B | TACI | 604907 | Immunoglobulin A deficiency type 2 | IGAD2 | 609529 | SEQ, NGS | T | Meta |
TNFRSF1A | 191190 | Familial periodic fever | tumor necrosis factor receptor-associated periodic syndrome (TRAPS) | 142680 | SEQ, NGS | T | Fever | |
TNNI3 | 191044 | Cardiomyopathy, dilated, 1FF | CMD1FF | 613286 | SEQ, NGS | T | Cardio | |
TNNI3 | 191044 | Cardiomyopathy, familial hypertrophic 7 | CMH7 | 613690 | SEQ, NGS | T | Cardio | |
TNNT2 | 191045 | Cardiomyopathy, dilated, 1D | CMD1D | 601494 | SEQ, MLPA, NGS | T | Cardio | |
TNNT2 | 191045 | Cardiomyopathy, familial hypertrophic 2 | CMH2 | 115195 | SEQ, MLPA, NGS | T | Cardio | |
TOR1A | 605204 | Torsion dystonia type 1 | DYT1 | 128100 | SEQ, MLPA, NGS | T | Neuro | |
TP53 | 191170 | Li-Fraumeni syndrome 1 | LFS1 | 151623 | SEQ, MLPA, NGS | T | Tumor | |
TP63 | p63, TP73L | 603273 | Acro-dermato-ungual-lacrimal-tooth syndrome | ADULT syndrome | 103285 | SEQ, NGS | T | Syndro |
TP63 | p63, TP73L | 603273 | AEC syndrome, Hay-Wells syndrome | 106260 | SEQ, NGS | T | Syndro | |
TP63 | p63, TP73L | 603273 | EEC syndrome 3 | ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 | 604292 | SEQ, NGS | T | Syndro |
TP63 | p63, TP73L | 603273 | Limb-mammary syndrome | 603543 | SEQ, NGS | T | Syndro | |
TP63 | p63, TP73L | 603273 | Rapp-Hodgkin syndrome | ectodermal dysplasia, anhidrotic, with cleft lip/palate | 129400 | SEQ, NGS | T | Syndro |
TP63 | p63, TP73L | 603273 | Split-hand/foot malformation type 4 | SHFM4 | 605289 | SEQ, NGS | T | Syndro |
TPM1 | 191010 | Cardiomyopathy, dilated,1Y | CMD1Y | 611878 | SEQ, NGS | T | Cardio | |
TPM1 | 191010 | Cardiomyopathy, familial hypertrophic 3 | CMH3 | 115196 | SEQ, NGS | T | Cardio | |
TPM2 | 190990 | Arthrogryposis multiplex congenita, distal type 1 | AMCD1 | 108120 | SEQ, NGS | T | Syndro | |
TPO | 606765 | Thyroid dyshormonogenesis type 2A | 274500 | SEQ, MLPA, NGS | T | Meta | ||
TPP1 | 607998 | Ceroid lipofuscinosis, neuronal, 2 | CLN2, Jansky-Bielschowsky disease, late infantile form included | 204500 | SEQ, MLPA, NGS | T | Meta | |
TRA rs1154155 | TRA@, T-cell receptor alpha, TCRA | 186880 | Narcolepsy type 5 | NRCLP5 | 612851 | SEQ | T | Neuro |
TRAPPC2 | 300202 | Spondyloepiphyseal dysplasia tarda, x-linked | SEDT | 313400 | SEQ, NGS | T | Tissue | |
TREM2 | 605086 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy-2 | PLOSL2 | 618193 | SEQ, NGS | T | Neuro | |
TREX1 | 606609 | Aicardi-Goutieres syndrome type 1 | AGS1 | 225750 | SEQ, MLPA, NGS | T | Syndro | |
TREX1 | 606609 | Chilblain lupus type 1 | CHBL1 | 610448 | SEQ, MLPA, NGS | T | Geno | |
TREX1 | 606609 | Hereditary endotheliopathy with retinopathy, nephropathy, and stroke | HERNS syndrome | 192315 | SEQ, MLPA, NGS | T | Syndro | |
TREX1 | 606609 | Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations | RVCLS, cerebroretinal vasculopathy, hereditary, CRV | 192315 | SEQ, MLPA, NGS | T | Syndro | |
TRPS1 | 604386 | Trichorhinophalangeal syndrome, type I | 190350 | SEQ, MLPA, NGS | T | Tissue | ||
TRPS1 | 604386 | Trichorhinophalangeal syndrome, type III | 190351 | SEQ, MLPA, NGS | T | Tissue | ||
TRPV4 | 605427 | Brachyolmia type 3 | 113500 | SEQ, NGS | T | Tissue | ||
TRPV4 | 605427 | Charcot-Marie-Tooth neuropathy type 2C | CMT2C, HMSN2C | 606071 | SEQ, NGS | T | Neuro | |
TRPV4 | 605427 | Metatropic dysplasia | Metatropic dwarfism | 156530 | SEQ, NGS | T | Tissue | |
TRPV4 | 605427 | Parastremmatic dwarfism | 168400 | SEQ, NGS | T | Tissue | ||
TRPV4 | 605427 | Scapuloperoneal spinal muscular atrophy | SPSMA, New England type | 181405 | SEQ, NGS | T | Neuro | |
TRPV4 | 605427 | Spinal muscular atrophy distal, congenital, nonprogressive | Spinal muscular atrophy, distal, congenital benign, with contractures | 600175 | SEQ, NGS | T | Neuro | |
TRPV4 | 605427 | Spondyloepiphyseal dysplasia, maroteaux type | SED, pseudo-Morquio syndrome, type 2 | 184095 | SEQ, NGS | T | Tissue | |
TRPV4 | 605427 | Spondylometaphyseal dysplasia, Kozlowski type | 184252 | SEQ, NGS | T | Tissue | ||
TSC1 | 605284 | Tuberous sclerosis 1 | TSC1 | 191100 | SEQ, MLPA, NGS | T | Tumor | |
TSC2 | 191092 | Tuberous sclerosis 2 | TSC2 | 613254 | SEQ, MLPA, NGS | T | Tumor | |
TSEN2 | 608753 | Pontocerebellar hypoplasia type 2B | PCH2B | 612389 | SEQ, NGS | T | Neuro | |
TSEN34 | 608754 | Pontocerebellar hypoplasia type 2C | PCH2C | 612390 | SEQ, NGS | T | Neuro | |
TSEN54 | 608755 | Pontocerebellar hypoplasia type 2A | PCH2A | 277470 | SEQ, NGS | T | Neuro | |
TSEN54 | 608755 | Pontocerebellar hypoplasia type 4 | PCH4 | 225753 | SEQ, NGS | T | Neuro | |
TSHR | 603372 | Congenital nongoitrous hypothyroidism-1 | CHNG1 | 275200 | SEQ, MLPA, NGS | T | Meta | |
TSHR | 603372 | Familial gestational hyperthyroidism | 603373 | SEQ, MLPA, NGS | T | Meta | ||
TSHR | 603372 | Nonautoimmune hyperthyroidism | 609152 | SEQ, MLPA, NGS | T | Meta | ||
TTBK2 | 611695 | Spinocerebellar ataxia type 11 | SCA11 | 604432 | SEQ, NGS | T | Neuro | |
TTR | 176300 | Amyloidosis, hereditary, transthyretin-related | Amyloid polyneuropathy | 105210 | SEQ, NGS | T | Meta | |
TUBA1A | 602529 | Lissencephaly type 3 | LIS3 | 611603 | SEQ, NGS | T | Syndro | |
TUBB3 | 602661 | Complex cortical dysplasia with other brain malformations type 1 | CDCBM1 | 614039 | SEQ, NGS | T | Neuro | |
TUBB3 | 602661 | Congenital fibrosis of extraocular muscles type 3A | CFEOM3A | 600638 | SEQ, NGS | T | Sensory | |
TUBGCP6 | 610053 | Microcephaly and chorioretinopathy, autosomal recessive | 251270 | SEQ, NGS | T | Syndro | ||
TWIST1 | 601622 | Craniosynostosis type 1 | CRS1 | 123100 | SEQ, MLPA, NGS | T | Syndro | |
TWIST1 | 601622 | Saethre-Chotzen syndrome | SCS, acrocephalosyndactyly, type III | 101400 | SEQ, MLPA, NGS | T | Syndro | |
TWIST1 | 601622 | Saethre-Chotzen syndrome with eyelid anomalies | 101400 | SEQ, MLPA, NGS | T | Syndro | ||
TWNK | C10ORF2, TWINKLE | 606075 | Chronic progressive external ophthalmoplegia type 3, | CPEO3, progressive external ophthalmoplegia 3, PEOA3 | 609286 | SEQ, MLPA, NGS | T | Neuro |
TWNK | C10ORF2, TWINKLE | 606075 | Infantile-onset spinocerebellar ataxia, autosomal recessive | 271245 | SEQ, MLPA, NGS | T | Neuro | |
TWNK | C10ORF2, TWINKLE | 606075 | Mitochondrial DNA depletion syndrome type 7, hepatocerebral type | MTDPS7 | 271245 | SEQ, MLPA, NGS | T | Neuro |
TWNK | C10orf2, TWINKLE | 606075 | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, type 3 | 609286 | SEQ, MLPA, NGS | T | Neuro | |
TYK2 | 176941 | Hyper-IgE syndrome with atypical mycobacteriosis, autosomal recessive | Immunodeficiency 35, tyrosine kinase 2 deficiency | 611521 | SEQ, NGS | T | Meta | |
TYMP | ECGF1 | 131222 | Mitochondrial DNA depletion syndrome type 1 | MNGIE, Mitochondrial neurogastrointestinal encephalopathy syndrome, MTDPS1 | 603041 | SEQ, NGS | T | Neuro |
TYR hypomorphic mutation | 606933 | Albinism, oculocutaneous, type 1B | OCA1B, tyrosinase-positive OCA1 | 606952 | SEQ, MLPA, NGS | T | Meta | |
TYR null mutation | 606933 | Albinism, oculocutaneous, type 1A | OCA1A, tyrosinase-negative OCA1 | 203100 | SEQ, MLPA, NGS | T | Meta | |
TYRP1 | 115501 | Albinism, oculocutaneous, type 3 | OCA3 | 203290 | SEQ, NGS | T | Meta | |
UCHL1 | 191342 | Parkinson disease, autosomal dominant, type 5 | PARK5 | 613643 | SEQ, MLPA, NGS | U | Neuro | |
UCHL1 | 191342 | Spastic paraplegia type 79, autosomal recessive | SPG79, neurodegeneration with optic atrophy | 615491 | SEQ, MLPA, NGS | U | Neuro | |
UGT1A1 | UGT1 | 191740 | Crigler-Najjar syndrome type I | Hyperbilirubinemia, Crigler-Najjar type I (HBLRCN1) | 218800 | SEQ, NGS | U | Meta |
UGT1A1 | UGT1 | 191740 | Crigler-Najjar syndrome type II | Hyperbilirubinemia, Crigler-Najjar type II (HBLRCN2) | 606785 | SEQ, NGS | U | Meta |
UGT1A1 | UGT1 | 191740 | Gilbert syndrome | 143500 | SEQ, NGS | U | Meta | |
UMOD | 191845 | Glomerulocystic kidney disease with hyperuricemia and isosthenuria | 609886 | SEQ, NGS | U | Meta | ||
UMOD | 191845 | Hyperuricemic nephropathy, familial juvenile, 1 | HNFJ1 | 162000 | SEQ, NGS | U | Meta | |
UMOD | 191845 | Medullary cystic kidney disease 2 | MCKD2 | 603860 | SEQ, NGS | U | Meta | |
UROD | 613521 | Porphyria cutanea tarda | Uroporphyrinogen decarboxylase deficiency | 176100 | SEQ, MLPA, NGS | U | Meta | |
VAPB | 605704 | Amyotrophic lateral sclerosis type 8 | ALS8 | 608627 | SEQ, NGS | V | Neuro | |
VAPB | 605704 | Spinal muscular atrophy, proximal, late-onset, autosomal dominant | Spinal muscular atrophy Finkel type | 182980 | SEQ, NGS | V | Neuro | |
VCP | 601023 | Amyotrophic lateral sclerosis type 14, with or without frontotemporal dementia | ALS14 | 613954 | SEQ, NGS | V | Neuro | |
VCP | 601023 | Charcot-Marie-Tooth neuropathy type 2Y | CMT2Y | 616687 | SEQ, NGS | V | Neuro | |
VCP | 601023 | Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia | IBMPFD1 | 167320 | SEQ, NGS | V | Neuro | |
VHL | 608537 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | V | Kidney | |
VHL | 608537 | Pheochromocytoma | PCC | 171300 | SEQ, MLPA, NGS | V | Tumor | |
VHL | 608537 | Von Hippel-Lindau syndrome | VHL | 193300 | SEQ, MLPA, NGS | V | Kidney | |
VHL | 608537 | Von Hippel-Lindau syndrome | VHL | 193300 | SEQ, MLPA, NGS | V | Tumor | |
VLDLR | 192977 | Cerebellar ataxia, mental retardation and dysequilibrium syndrome 1 | CAMRQ1 | 224050 | SEQ, MLPA, NGS | V | Neuro | |
VPS13A | 605978 | Choreoacanthocytosis | Neuroacanthocytosis, Levine-Critchley syndrome | 200150 | SEQ, NGS | V | Neuro | |
VPS13B | 607817 | Cohen syndrome | COH1 | 216550 | SEQ, MLPA, NGS | V | Syndro | |
WASHC5 | KIAA0196 | 610657 | Spastic paraplegia type 8, autosomal dominant, | SPG8 | 603563 | SEQ, NGS | W | Neuro |
WDR45 | 300526 | Neurodegeneration with brain iron accumulation, type 5 | NBIA5 | 300894 | SEQ, NGS | W | Neuro | |
WNT10A | 606268 | Odontoonychodermal dysplasia | OODD | 257980 | SEQ, MLPA, NGS | W | Syndro | |
WNT10A | 606268 | Schopf-Schulz-Passarge syndrome | SSPS, keratosis, palmoplantaris with cystic eyelids, hypodontia, and hypotrichosis | 606268 | SEQ, MLPA, NGS | W | Syndro | |
WNT10A | 606268 | Tooth agenesis-4 with or without ectodermal dysplasia | STHAG4, absence of lateral incisors | 150400 | SEQ, MLPA, NGS | W | Syndro | |
WNT5A | 164975 | Robinow syndrome, autosomal dominant | 180700 | SEQ, NGS | W | Syndro | ||
WRN | RECQL2 | 604611 | Werner syndrome | 277700 | SEQ, NGS | W | Syndro | |
XK | 314850 | McLeod syndrome | MCLDS | 300842 | SEQ, NGS | X | Neuro | |
XPR1 | 605237 | Basal ganglia calcification, idiopathic, type 6, Fahr disease | IBGC6 | 616413 | SEQ, NGS | X | Neuro | |
ZFYVE26 | KIAA0321, Spastizin | 612012 | Spastic paraplegia type 15, autosomal recessive | SPG15, spastic paraplegia and retinal degeneration, Kjellin syndrome | 270700 | SEQ, NGS | Z | Neuro |